Frank Tacke

Frank Tacke's AcademicInfluence.com Rankings

Frank Tacke

Physics

#2530

World Rank

#3728

Historical Rank

physics Degrees

Download Badge

Physics

Why Is Frank Tacke Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Frank Tacke's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection. (2017) (2984)
Monocyte subsets differentially employ CCR2, CCR5, and CX3CR1 to accumulate within atherosclerotic plaques. (2007) (1267)
Senescence surveillance of pre-malignant hepatocytes limits liver cancer development (2011) (1133)
Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study. (2018) (1034)
Global Perspectives on Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis (2019) (915)
Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016-2030. (2018) (881)
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1 (2021) (811)
Liver macrophages in tissue homeostasis and disease (2017) (773)
Micro‐RNA profiling reveals a role for miR‐29 in human and murine liver fibrosis (2011) (727)
Langerhans cells arise from monocytes in vivo (2006) (722)
Macrophage heterogeneity in liver injury and fibrosis. (2014) (707)
Alloantigen-presenting plasmacytoid dendritic cells mediate tolerance to vascularized grafts (2006) (692)
Hepatic recruitment of the inflammatory Gr1+ monocyte subset upon liver injury promotes hepatic fibrosis (2009) (690)
Immunology in the liver — from homeostasis to disease (2016) (664)
Comparison of gene expression profiles between human and mouse monocyte subsets. (2010) (661)
Resolving the fibrotic niche of human liver cirrhosis at single cell level (2019) (619)
Deep learning can predict microsatellite instability directly from histology in gastrointestinal cancer (2019) (597)
Roles for chemokines in liver disease. (2014) (585)
Targeting hepatic macrophages to treat liver diseases. (2017) (580)
Migratory fate and differentiation of blood monocyte subsets. (2006) (569)
A randomized, placebo‐controlled trial of cenicriviroc for treatment of nonalcoholic steatohepatitis with fibrosis (2018) (481)
Pharmacological inhibition of the chemokine CCL2 (MCP-1) diminishes liver macrophage infiltration and steatohepatitis in chronic hepatic injury (2011) (458)
Protective Role of CXC Receptor 4/CXC Ligand 12 Unveils the Importance of Neutrophils in Atherosclerosis (2008) (420)
Hepatic macrophages in homeostasis and liver diseases: from pathogenesis to novel therapeutic strategies (2016) (373)
Inflammatory Pathways in Liver Homeostasis and Liver Injury (2009) (373)
Gene expression changes in foam cells and the role of chemokine receptor CCR7 during atherosclerosis regression in ApoE-deficient mice. (2006) (347)
Role of CCR8 and Other Chemokine Pathways in the Migration of Monocyte-derived Dendritic Cells to Lymph Nodes (2004) (331)
Hepatic acute-phase proteins control innate immune responses during infection by promoting myeloid-derived suppressor cell function (2010) (321)
Therapeutic inhibition of inflammatory monocyte recruitment reduces steatohepatitis and liver fibrosis (2018) (316)
Selection of Hepatitis B Virus Polymerase Mutations in HIV-Coinfected Patients Treated with Tenofovir (2005) (306)
Immature monocytes acquire antigens from other cells in the bone marrow and present them to T cells after maturing in the periphery (2006) (302)
Functional Contribution of Elevated Circulating and Hepatic Non-Classical CD14+CD16+ Monocytes to Inflammation and Human Liver Fibrosis (2010) (301)
Liver — guardian, modifier and target of sepsis (2017) (301)
Age-dependent alterations of monocyte subsets and monocyte-related chemokine pathways in healthy adults (2010) (297)
Experimental liver fibrosis research: update on animal models, legal issues and translational aspects (2013) (293)
Organ and tissue fibrosis: Molecular signals, cellular mechanisms and translational implications. (2019) (282)
Circulating soluble urokinase plasminogen activator receptor is stably elevated during the first week of treatment in the intensive care unit and predicts mortality in critically ill patients (2011) (275)
Modulation of Dendritic Cell Trafficking to and from the Airways (2006) (271)
Blood Monocyte Subsets Differentially Give Rise to CD103+ and CD103− Pulmonary Dendritic Cell Populations1 (2008) (258)
Liver inflammation abrogates immunological tolerance induced by Kupffer cells (2015) (256)
Role of IL-17 and Th17 Cells in Liver Diseases (2010) (248)
Bile Duct Ligation in Mice: Induction of Inflammatory Liver Injury and Fibrosis by Obstructive Cholestasis (2015) (244)
Interleukin-8 Is Activated in Patients with Chronic Liver Diseases and Associated with Hepatic Macrophage Accumulation in Human Liver Fibrosis (2011) (241)
Usefulness of suPAR as a biological marker in patients with systemic inflammation or infection: a systematic review (2012) (226)
Chemokine (C‐C motif) receptor 2–positive monocytes aggravate the early phase of acetaminophen‐induced acute liver injury (2016) (225)
Functional Role of Monocytes and Macrophages for the Inflammatory Response in Acute Liver Injury (2012) (223)
CCL2-dependent infiltrating macrophages promote angiogenesis in progressive liver fibrosis (2014) (217)
A positive feedback loop between RIP3 and JNK controls non-alcoholic steatohepatitis (2014) (216)
The fractalkine receptor CX3CR1 protects against liver fibrosis by controlling differentiation and survival of infiltrating hepatic monocytes (2010) (215)
TAK1 suppresses a NEMO-dependent but NF-kappaB-independent pathway to liver cancer. (2010) (215)
Cellular and molecular functions of hepatic stellate cells in inflammatory responses and liver immunology. (2014) (214)
Monocytic suppressive cells mediate cardiovascular transplantation tolerance in mice. (2010) (204)
Platelet GPIbα is a mediator and potential interventional target for NASH and subsequent liver cancer (2019) (203)
Pharmacological inhibition of the chemokine C‐C motif chemokine ligand 2 (monocyte chemoattractant protein 1) accelerates liver fibrosis regression by suppressing Ly‐6C+ macrophage infiltration in mice (2014) (202)
Chemokine Receptor CXCR6-Dependent Hepatic NK T Cell Accumulation Promotes Inflammation and Liver Fibrosis (2013) (199)
Liver Macrophages: Old Dogmas and New Insights (2019) (188)
Two distinct types of Langerhans cells populate the skin during steady state and inflammation. (2012) (188)
Monocytes and macrophages as cellular targets in liver fibrosis. (2009) (179)
Update on hepatic stellate cells: pathogenic role in liver fibrosis and novel isolation techniques (2012) (167)
Advancing the global public health agenda for NAFLD: a consensus statement (2021) (167)
Immune mechanisms in acetaminophen-induced acute liver failure. (2014) (167)
Cenicriviroc Treatment for Adults With Nonalcoholic Steatohepatitis and Fibrosis: Final Analysis of the Phase 2b CENTAUR Study (2020) (165)
M-CSF and GM-CSF Receptor Signaling Differentially Regulate Monocyte Maturation and Macrophage Polarization in the Tumor Microenvironment. (2016) (164)
The concanavalin A model of acute hepatitis in mice (2015) (164)
Molecular identification of hepatitis B virus genotypes/subgenotypes: revised classification hurdles and updated resolutions. (2014) (162)
Hepatic macrophages in liver homeostasis and diseases-diversity, plasticity and therapeutic opportunities (2020) (161)
Serum resistin levels in critically ill patients are associated with inflammation, organ dysfunction and metabolism and may predict survival of non-septic patients (2009) (161)
Interleukin 6/gp130‐dependent pathways are protective during chronic liver diseases (2003) (156)
Adaptive immunity suppresses formation and progression of diethylnitrosamine-induced liver cancer (2012) (154)
Macrophages in obesity and non-alcoholic fatty liver disease: Crosstalk with metabolism (2019) (150)
GLP-1 Secretion Is Increased by Inflammatory Stimuli in an IL-6–Dependent Manner, Leading to Hyperinsulinemia and Blood Glucose Lowering (2014) (149)
Antifibrotic effects of CXCL9 and its receptor CXCR3 in livers of mice and humans. (2009) (147)
Hepatic macrophage migration and differentiation critical for liver fibrosis is mediated by the chemokine receptor C‐C motif chemokine receptor 8 in mice (2012) (147)
Mechanisms of liver fibrosis resolution. (2015) (146)
Circulating MicroRNA-150 Serum Levels Predict Survival in Patients with Critical Illness and Sepsis (2013) (145)
U6 is unsuitable for normalization of serum miRNA levels in patients with sepsis or liver fibrosis (2013) (144)
The rtA194T polymerase mutation impacts viral replication and susceptibility to tenofovir in hepatitis B e antigen–positive and hepatitis B e antigen–negative hepatitis B virus strains (2009) (143)
Auto-aggressive CXCR6+ CD8 T cells cause liver immune pathology in NASH (2021) (140)
Chemokine receptor CCR6‐dependent accumulation of γδ T cells in injured liver restricts hepatic inflammation and fibrosis (2014) (136)
Tip-DC Development during Parasitic Infection Is Regulated by IL-10 and Requires CCL2/CCR2, IFN-γ and MyD88 Signaling (2010) (135)
Chemokine-directed immune cell infiltration in acute and chronic liver disease (2008) (127)
Peptide-functionalized gold nanorods increase liver injury in hepatitis. (2012) (127)
Liver Fibrosis: From Pathogenesis to Novel Therapies (2016) (127)
Basal Core Promoter and Precore Mutations in the Hepatitis B Virus Genome Enhance Replication Efficacy of Lamivudine-Resistant Mutants (2004) (126)
An elevated FIB-4 score predicts liver cancer development: a longitudinal analysis from 29,999 NAFLD patients: Reply to: "EASL Clinical Practice Guidelines on non-invasive tests for evaluation of liver disease severity and prognosis- 2021 update". (2021) (126)
Seven weeks of Western diet in apolipoprotein-E-deficient mice induce metabolic syndrome and non-alcoholic steatohepatitis with liver fibrosis (2015) (122)
High adiponectin in chronic liver disease and cholestasis suggests biliary route of adiponectin excretion in vivo. (2005) (121)
RIP3 inhibits inflammatory hepatocarcinogenesis but promotes cholestasis by controlling caspase-8- and JNK-dependent compensatory cell proliferation. (2013) (120)
Dexamethasone nanomedicines for COVID-19 (2020) (119)
Etiologies and outcomes of acute liver failure in Germany. (2012) (118)
Modification of chemokine pathways and immune cell infiltration as a novel therapeutic approach in liver inflammation and fibrosis. (2011) (118)
Report on the AASLD/EASL Joint Workshop on Clinical Trial Endpoints in NAFLD (2019) (115)
miR-133a mediates TGF-β-dependent derepression of collagen synthesis in hepatic stellate cells during liver fibrosis. (2013) (115)
Nonalcoholic steatohepatitis: the role of peroxisome proliferator-activated receptors (2020) (115)
Loss of caspase-8 protects mice against inflammation-related hepatocarcinogenesis but induces non-apoptotic liver injury. (2011) (113)
Acetaminophen-induced acute liver injury in mice (2015) (112)
Myeloid cells in liver and bone marrow acquire a functionally distinct inflammatory phenotype during obesity-related steatohepatitis (2019) (112)
Single Cell RNA Sequencing Identifies Subsets of Hepatic Stellate Cells and Myofibroblasts in Liver Fibrosis (2019) (111)
Therapeutic targeting of liver inflammation and fibrosis by nanomedicine. (2014) (110)
Ghrelin in chronic liver disease. (2003) (109)
Differential effects of selective- and pan-PPAR agonists on experimental steatohepatitis and hepatic macrophages. (2020) (108)
American Journal of Physiology: Gastrointestinal and Liver Physiology American Journal of Physiology: Heart and Circulatory Physi- QlQgY American Journal of Physiology: Regulatory, Integrative and Comparative Physiology American Journal of Physiology: Renal, Fluid and Electrolyte (2003) (108)
Levels of Circulating miR-133a Are Elevated in Sepsis and Predict Mortality in Critically Ill Patients (2014) (108)
Protective effects of lipocalin-2 (LCN2) in acute liver injury suggest a novel function in liver homeostasis. (2013) (106)
Regardless of etiology, progressive renal disease causes ultrastructural and functional alterations of peritubular capillaries. (2017) (105)
Administration of proton pump inhibitors in critically ill medical patients is associated with increased risk of developing Clostridium difficile-associated diarrhea. (2014) (104)
Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study. (2022) (103)
Micro-RNA Profiling in Human Serum Reveals Compartment-Specific Roles of miR-571 and miR-652 in Liver Cirrhosis (2012) (102)
Fluorescent cell-traceable dexamethasone-loaded liposomes for the treatment of inflammatory liver diseases. (2015) (102)
Comparison of gene expression profiles between human and mouse monocyte (2016) (101)
Interleukins in chronic liver disease: lessons learned from experimental mouse models (2014) (100)
CCR2 Mediates Homeostatic and Inflammatory Release of Gr1high Monocytes from the Bone Marrow, but Is Dispensable for Bladder Infiltration in Bacterial Urinary Tract Infection1 (2008) (100)
A cross-sectional study of the public health response to non-alcoholic fatty liver disease in Europe. (2020) (98)
Global Perspectives on Non-alcoholic Fatty Liver Disease and Non-alcoholic Steatohepatitis (96)
Elevated miR‐122 serum levels are an independent marker of liver injury in inflammatory diseases (2015) (94)
[S2k Guideline non-alcoholic fatty liver disease]. (2015) (92)
Somatostatin Analogues in the Treatment of Neuroendocrine Tumors: Past, Present and Future (2019) (91)
Cenicriviroc for the treatment of non-alcoholic steatohepatitis and liver fibrosis (2018) (90)
Resistin Serum Levels Are Associated with Insulin Resistance, Disease Severity, Clinical Complications, and Prognosis in Patients with Chronic Liver Diseases (2006) (90)
Functional role of intrahepatic monocyte subsets for the progression of liver inflammation and liver fibrosis in vivo (2012) (88)
Solid organ transplantation programs facing lack of empiric evidence in the COVID-19 pandemic: A By-proxy Society Recommendation Consensus approach (2020) (87)
CX3CR1 is a gatekeeper for intestinal barrier integrity in mice: Limiting steatohepatitis by maintaining intestinal homeostasis (2015) (86)
Acute liver failure: a life-threatening disease. (2011) (85)
Fibrosis imaging: Current concepts and future directions. (2017) (84)
[S2k Guideline Gastrointestinal Bleeding - Guideline of the German Society of Gastroenterology DGVS]. (2017) (83)
Serum adiponectin upon admission to the intensive care unit may predict mortality in critically ill patients. (2011) (82)
Liposomal encapsulation of dexamethasone modulates cytotoxicity, inflammatory cytokine response, and migratory properties of primary human macrophages. (2014) (80)
Pharmacological Intervention in Hepatic Stellate Cell Activation and Hepatic Fibrosis (2016) (78)
Iron Parameters Determine the Prognosis of Critically Ill Patients* (2016) (77)
Serum chemokine CXC ligand 10 (CXCL10) predicts fibrosis progression after liver transplantation for hepatitis C infection (2011) (77)
Circulating soluble urokinase plasminogen activator is elevated in patients with chronic liver disease, discriminates stage and aetiology of cirrhosis and predicts prognosis (2011) (76)
Effects of aging on liver microcirculatory function and sinusoidal phenotype (2018) (75)
C/EBP β isoforms LIP and LAP modulate progression of the cell cycle in the regenerating mouse liver (2004) (74)
Cenicriviroc for the treatment of liver fibrosis in adults with nonalcoholic steatohepatitis: AURORA Phase 3 study design. (2019) (74)
TNFα-Mediated Liver Destruction by Kupffer Cells and Ly6Chi Monocytes during Entamoeba histolytica Infection (2013) (73)
Soluble Urokinase Receptor (SuPAR) in COVID-19-Related AKI. (2020) (73)
Recent advances in understanding liver fibrosis: bridging basic science and individualized treatment concepts (2018) (73)
CXCR6 Inhibits Hepatocarcinogenesis by Promoting Natural Killer T- and CD4+ T-Cell-Dependent Control of Senescence. (2019) (71)
S2k-Leitlinie Gastrointestinale Blutung (2017) (69)
Report on the AASLD/EASL joint workshop on clinical trial endpoints in NAFLD. (2019) (69)
Intestinal Virome Signature Associated With Severity of Nonalcoholic Fatty Liver Disease. (2020) (69)
Stromal cell-derived factor-1 (SDF-1) as a target in liver diseases. (2016) (68)
Histidine‐rich glycoprotein promotes macrophage activation and inflammation in chronic liver disease (2016) (68)
The fractalkine receptor CX3CR1 is involved in liver fibrosis due to chronic hepatitis C infection. (2008) (68)
Monocytes in health and disease - Minireview. (2012) (67)
Elevation of Nepsilon-(carboxymethyl)lysine-modified advanced glycation end products in chronic liver disease is an indicator of liver cirrhosis. (2006) (67)
Overexpression of c-myc in hepatocytes promotes activation of hepatic stellate cells and facilitates the onset of liver fibrosis. (2013) (66)
microRNA 193a-5p Regulates Levels of Nucleolar- and Spindle-Associated Protein 1 to Suppress Hepatocarcinogenesis. (2018) (66)
RIPK1 Suppresses a TRAF2-Dependent Pathway to Liver Cancer. (2017) (65)
Relevance of Serum Leptin and Leptin-Receptor Concentrations in Critically Ill Patients (2010) (64)
Increased liver stiffness denotes hepatic dysfunction and mortality risk in critically ill non-cirrhotic patients at a medical ICU (2011) (63)
Role of lymphocytes in liver cancer (2013) (63)
Role of chemokine pathways in hepatobiliary cancer. (2016) (61)
Elevated levels of circulating osteopontin are associated with a poor survival after resection of cholangiocarcinoma. (2017) (61)
Bone Morphogenetic Protein 7 is Elevated in Patients with Chronic Liver Disease and Exerts Fibrogenic Effects on Human Hepatic Stellate Cells (2007) (61)
CEA but not CA19-9 is an independent prognostic factor in patients undergoing resection of cholangiocarcinoma (2017) (61)
Machine perfusion for liver transplantation in the era of marginal organs—New kids on the block (2018) (60)
The role of chemokines and their receptors in dendritic cell biology. (2008) (60)
Pharmacological Inhibition of the Chemokine CXCL16 Diminishes Liver Macrophage Infiltration and Steatohepatitis in Chronic Hepatic Injury (2014) (60)
Role of gamma-delta T cells in liver inflammation and fibrosis. (2014) (59)
Elevated apoptosis-associated cytokeratin 18 fragments (CK18Asp386) in serum of patients with chronic liver diseases indicate hepatic and biliary inflammation. (2007) (59)
The necroptosis-inducing kinase RIPK3 dampens adipose tissue inflammation and glucose intolerance (2016) (59)
Insulin resistance in liver cirrhosis is not associated with circulating retinol-binding protein 4. (2007) (59)
An update on the recent advances in antifibrotic therapy (2018) (58)
Liver transplantation in Germany (2016) (58)
The CCR2+ Macrophage Subset Promotes Pathogenic Angiogenesis for Tumor Vascularization in Fibrotic Livers (2018) (58)
miR‐30c and miR‐193 are a part of the TGF‐β‐dependent regulatory network controlling extracellular matrix genes in liver fibrosis (2015) (57)
Validation of connective tissue growth factor (CTGF/CCN2) and its gene polymorphisms as noninvasive biomarkers for the assessment of liver fibrosis (2009) (57)
Growth Differentiation Factor-15 Is a Predictor of Mortality in Critically Ill Patients with Sepsis (2017) (56)
YB-1 Is an Early and Central Mediator of Bacterial and Sterile Inflammation In Vivo (2013) (56)
Regulation and prognostic relevance of serum ghrelin concentrations in critical illness and sepsis (2010) (56)
The global NAFLD policy review and preparedness index: Are countries ready to address this silent public health challenge? (2021) (56)
Serum chemokine receptor CXCR3 ligands are associated with progression, organ dysfunction and complications of chronic liver diseases (2011) (56)
Primary Cultures of Glomerular Parietal Epithelial Cells or Podocytes with Proven Origin (2012) (55)
Hypothermic oxygenated machine perfusion (HOPE) for orthotopic liver transplantation of human liver allografts from extended criteria donors (ECD) in donation after brain death (DBD): a prospective multicentre randomised controlled trial (HOPE ECD-DBD) (2017) (55)
Induction of experimental obstructive cholestasis in mice (2015) (54)
Mouse models of hepatocarcinogenesis: What can we learn for the prevention of human hepatocellular carcinoma? (2010) (54)
Prevention of stress-related ulcer bleeding at the intensive care unit: Risks and benefits of stress ulcer prophylaxis. (2016) (54)
CXCL9 is a prognostic marker in patients with liver cirrhosis receiving transjugular intrahepatic portosystemic shunt. (2015) (54)
Targeting distinct myeloid cell populations in vivo using polymers, liposomes and microbubbles. (2017) (53)
Elevated circulating soluble interleukin-2 receptor in patients with chronic liver diseases is associated with non-classical monocytes (2012) (53)
Prognostic value of circulating amino-terminal pro-C-type natriuretic peptide in critically ill patients (2011) (52)
Relevance of Autophagy in Parenchymal and Non-Parenchymal Liver Cells for Health and Disease (2019) (52)
Studying the pathophysiology of coronavirus disease 2019: a protocol for the Berlin prospective COVID-19 patient cohort (Pa-COVID-19) (2020) (51)
Differential regulation of chemokine CCL5 expression in monocytes/macrophages and renal cells by Y-box protein-1. (2009) (51)
Hepatocyte‐specific inhibitor‐of‐kappaB‐kinase deletion triggers the innate immune response and promotes earlier cell proliferation during liver regeneration (2008) (50)
Hyaluronan serum concentrations are elevated in critically ill patients and associated with disease severity. (2012) (49)
[ALT screening for chronic liver diseases: scrutinizing the evidence]. (2010) (49)
IκB kinaseα/β control biliary homeostasis and hepatocarcinogenesis in mice by phosphorylating the cell‐death mediator receptor‐interacting protein kinase 1 (2016) (49)
Selection of the highly replicative and partially multidrug resistant rtS78T HBV polymerase mutation during TDF-ETV combination therapy. (2017) (48)
Ischemia-Reperfusion Injury in Marginal Liver Grafts and the Role of Hypothermic Machine Perfusion: Molecular Mechanisms and Clinical Implications (2020) (48)
CREB/PKA sensitive signalling pathways activate and maintain expression levels of the hepatitis B virus pre-S2/S promoter (2005) (48)
Elevated asymmetric dimethylarginine levels predict short- and long-term mortality risk in critically ill patients. (2013) (48)
Cyclin E1 controls proliferation of hepatic stellate cells and is essential for liver fibrogenesis in mice (2012) (47)
Differential Impact of Immune Escape Mutations G145R and P120T on the Replication of Lamivudine-Resistant Hepatitis B Virus e Antigen-Positive and -Negative Strains (2009) (47)
Differential impact of the dual CCR2/CCR5 inhibitor cenicriviroc on migration of monocyte and lymphocyte subsets in acute liver injury (2017) (46)
The prognostic role of lymphovascular invasion and lymph node metastasis in perihilar and intrahepatic cholangiocarcinoma. (2019) (46)
Therapeutic depletion of CCR8+ tumor-infiltrating regulatory T cells elicits antitumor immunity and synergizes with anti-PD-1 therapy (2021) (46)
Down-regulation of miR-192-5p protects from oxidative stress-induced acute liver injury. (2016) (45)
Studying the pathophysiology of coronavirus disease 2019 - a protocol for the Berlin prospective COVID-19 patient cohort (Pa- COVID-19) (2020) (45)
Inhibition of LTβR-signalling activates Wnt-induced regeneration in lung (2020) (45)
Chemokines in liver inflammation and fibrosis. (2010) (45)
The NLRP3 Inflammasome in Alcoholic and Nonalcoholic Steatohepatitis (2020) (44)
Transient portal vein thrombosis in liver cirrhosis (2018) (44)
Management of hepatitis C virus infection in the Asia-Pacific region: an update. (2017) (44)
Circulating retinol binding protein 4 in critically ill patients before specific treatment: prognostic impact and correlation with organ function, metabolism and inflammation (2010) (43)
Gene expression changes in foam cells and the role of chemokine receptor CCR 7 during atherosclerosis regression in ApoE-deficient mice (2006) (43)
New drugs for NAFLD: lessons from basic models to the clinic (2019) (43)
Targeting CCl4‐induced liver fibrosis by RNA interference–mediated inhibition of cyclin E1 in mice (2017) (42)
RIPK1 suppresses a TRAF2-dependent pathway to liver cancer (2017) (42)
The chemokine scavenging receptor D6 limits acute toxic liver injury in vivo (2009) (42)
Soluble urokinase plasminogen activator receptor is compartmentally regulated in decompensated cirrhosis and indicates immune activation and short‐term mortality (2013) (42)
Differential Induction of Ly6G and Ly6C Positive Myeloid Derived Suppressor Cells in Chronic Kidney and Liver Inflammation and Fibrosis (2015) (42)
Glucocorticoid-loaded liposomes induce a pro-resolution phenotype in human primary macrophages to support chronic wound healing. (2018) (42)
Elevated Soluble Urokinase Plasminogen Activator Receptor and Proenkephalin Serum Levels Predict the Development of Acute Kidney Injury after Cardiac Surgery (2017) (41)
GLP-1 Levels Predict Mortality in Patients with Critical Illness as Well as End-Stage Renal Disease. (2017) (41)
Treatment of HCV genotype 2 with sofosbuvir and ribavirin results in lower sustained virological response rates in real life than expected from clinical trials (2017) (41)
Isolation and Culture of Primary Murine Hepatic Stellate Cells. (2017) (41)
Macrophages in Nonalcoholic Fatty Liver Disease: A Role Model of Pathogenic Immunometabolism (2017) (41)
A Novel Model of Demyelinating Encephalomyelitis Induced by Monocytes and Dendritic Cells1 (2006) (41)
Emerging roles of myeloid derived suppressor cells in hepatic inflammation and fibrosis. (2015) (41)
Resolving the fibrotic niche of human liver cirrhosis using single-cell transcriptomics (2019) (41)
The role of the innate immune system in the development and treatment of hepatocellular carcinoma (2020) (41)
Clinical relevance and cellular source of elevated soluble urokinase plasminogen activator receptor (suPAR) in acute liver failure (2014) (40)
Non-alcoholic fatty liver disease (NAFLD)/non-alcoholic steatohepatitis (NASH)-related liver fibrosis: mechanisms, treatment and prevention (2020) (40)
Effects of nanoparticle surface-coupled peptides, functional endgroups, and charge on intracellular distribution and functionality of human primary reticuloendothelial cells. (2012) (40)
Gp130 Signaling Promotes Development of Acute Experimental Colitis by Facilitating Early Neutrophil/Macrophage Recruitment and Activation1 (2008) (40)
A simple clinical score predicts high risk for upper gastrointestinal hemorrhages from varices in patients with chronic liver disease (2007) (39)
Neutrophils are a main source of circulating suPAR predicting outcome in critical illness (2019) (38)
Lipocalin‐2 (NGAL/LCN2), a “help‐me” signal in organ inflammation (2016) (38)
Dendritic Cell and T Cell Crosstalk in Liver Fibrogenesis and Hepatocarcinogenesis: Implications for Prevention and Therapy of Liver Cancer (2020) (38)
miR-1224 inhibits cell proliferation in acute liver failure by targeting the antiapoptotic gene Nfib. (2017) (38)
Immune mechanisms linking metabolic injury to inflammation and fibrosis in fatty liver disease - novel insights into cellular communication circuits. (2022) (37)
p18(INK4c) collaborates with other CDK‐inhibitory proteins in the regenerating liver (2003) (37)
Acute hepatitis B virus infection by genotype F despite successful vaccination in an immune-competent German patient (2007) (37)
Dynamic plasticity of macrophage functions in diseased liver. (2017) (37)
Ly6C- Monocytes Regulate Parasite-Induced Liver Inflammation by Inducing the Differentiation of Pathogenic Ly6C+ Monocytes into Macrophages (2015) (37)
Prognostic Relevance of Altered Lymphocyte Subpopulations in Critical Illness and Sepsis (2019) (36)
CC Chemokine Ligand 18 in ANCA-Associated Crescentic GN. (2015) (36)
Serum levels of miR-29, miR-122, miR-155 and miR-192 are elevated in patients with cholangiocarcinoma (2019) (36)
Analysis of antigen-presenting functionality of cultured rat hepatic stellate cells and transdifferentiated myofibroblasts. (2010) (36)
Polymeric Selectin Ligands Mimicking Complex Carbohydrates: From Selectin Binders to Modifiers of Macrophage Migration. (2017) (36)
IL-6 and IL-8 Serum Levels Predict Tumor Response and Overall Survival after TACE for Primary and Secondary Hepatic Malignancies (2018) (36)
Persistently elevated osteopontin serum levels predict mortality in critically ill patients (2015) (36)
Elastin‐based molecular MRI of liver fibrosis (2013) (36)
Clinical and prognostic role of plasma coagulation factor XIII activity for bleeding disorders and 6‐year survival in patients with chronic liver disease (2006) (35)
The Medium-Chain Fatty Acid Receptor GPR84 Mediates Myeloid Cell Infiltration Promoting Steatohepatitis and Fibrosis (2020) (35)
Glucagon-Like Peptide 1 and Its Cleavage Products Are Renoprotective in Murine Diabetic Nephropathy (2018) (35)
Value of magnifying endoscopy in classifying colorectal polyps based on vascular pattern. (2009) (35)
CREMα overexpression decreases IL-2 production, induces a T(H)17 phenotype and accelerates autoimmunity. (2012) (35)
Influence of mutations in the hepatitis B virus genome on virus replication and drug resistance--implications for novel antiviral strategies. (2004) (35)
Regulation and Prognostic Relevance of Symmetric Dimethylarginine Serum Concentrations in Critical Illness and Sepsis (2013) (34)
Epithelial response to IFN‐γ promotes SARS‐CoV‐2 infection (2021) (34)
Polypropylene mesh implantation for hernia repair causes myeloid cell-driven persistent inflammation. (2019) (33)
Assessment of Inflammatory and Fibrotic Stenoses in Patients with Crohn’s Disease Using Contrast-Enhanced Ultrasound and Computerized Algorithm: A Pilot Study (2011) (33)
Circulating MicroRNA-223 Serum Levels Do Not Predict Sepsis or Survival in Patients with Critical Illness (2015) (33)
Distinct Patterns of IgG and IgA against Food and Microbial Antigens in Serum and Feces of Patients with Inflammatory Bowel Diseases (2014) (32)
The fecal mycobiome in non-alcoholic fatty liver disease (2021) (32)
Cyclic adenosine monophosphate–responsive element modulator alpha overexpression impairs function of hepatic myeloid‐derived suppressor cells and aggravates immune‐mediated hepatitis in mice (2015) (32)
S2k Leitlinie Autoimmune Lebererkrankungen (2017) (31)
Artificial Intelligence and Pathology: from Principles to Practice and Future Applications in Histomorphology and Molecular Profiling. (2021) (31)
Thrombopoietin serum levels are elevated in patients with hepatitis B/C infection compared to other causes of chronic liver disease. (2002) (31)
Sarcopenia Is a Negative Prognostic Factor in Patients Undergoing Transarterial Chemoembolization (TACE) for Hepatic Malignancies (2019) (31)
Prevalence, viral replication efficiency and antiviral drug susceptibility of rtQ215 polymerase mutations within the hepatitis B virus genome. (2009) (30)
Hypothermic Oxygenated Machine Perfusion Reduces Early Allograft Injury and Improves Post-transplant Outcomes in Extended Criteria Donation Liver Transplantation From Donation After Brain Death (2021) (30)
Immunomodulatory Therapy of Inflammatory Liver Disease Using Selectin-Binding Glycopolymers. (2017) (30)
Translation control of TAK1 mRNA by hnRNP K modulates LPS-induced macrophage activation (2014) (30)
Endoscopic ultrasound as an early diagnostic tool for primary sclerosing cholangitis: a prospective pilot study (2012) (30)
Enhanced expression of c-myc in hepatocytes promotes initiation and progression of alcoholic liver disease. (2015) (29)
Interleukin-33 in the pathogenesis of liver fibrosis: alarming ILC2 and hepatic stellate cells (2016) (29)
When Is a Critically Ill Cirrhotic Patient Too Sick to Transplant? Development of Consensus Criteria by a Multidisciplinary Panel of 35 International Experts. (2020) (29)
Tissue factor and thrombomodulin levels are correlated with stage of cirrhosis in patients with liver disease (2001) (29)
High C5a levels are associated with increased mortality in sepsis patients--no enhancing effect by actin-free Gc-globulin. (2008) (29)
Long term intravital multiphoton microscopy imaging of immune cells in healthy and diseased liver using CXCR6.Gfp reporter mice. (2015) (28)
Up‐regulated eotaxin plasma levels in chronic liver disease patients indicate hepatic inflammation, advanced fibrosis and adverse clinical course (2007) (28)
Factor VII activating protease (FSAP) exerts anti-inflammatory and anti-fibrotic effects in liver fibrosis in mice and men. (2013) (28)
Assessing the impact of COVID-19 on liver cancer management (CERO-19) (2021) (28)
From NAFLD to NASH to fibrosis to HCC: Role of dendritic cell populations in the liver (2013) (28)
Current and emerging pharmacotherapeutic interventions for the treatment of liver fibrosis (2020) (28)
Isolation and Time Lapse Microscopy of Highly Pure Hepatic Stellate Cells (2015) (27)
Cenicriviroc placebo for the treatment of non-alcoholic steatohepatitis with liver fibrosis: Results from the Year 1 primary analysis of the Phase 2b CENTAUR study (2016) (27)
Systemic treatment of hepatocellular carcinoma: from sorafenib to combination therapies (2020) (27)
Receptor interacting protein kinase 1 (RIPK1) in hepatocytes does not mediate murine acetaminophen toxicity (2016) (27)
High prevalence of Y-box protein-1/p18 fragment in plasma of patients with malignancies of different origin (2014) (27)
Left- versus right-sided hepatectomy with hilar en-bloc resection in perihilar cholangiocarcinoma. (2020) (26)
Symptomatic hepatitis B virus (HBV) reactivation despite reduced viral fitness is associated with HBV test and immune escape mutations in an HIV-coinfected patient. (2008) (26)
CXCL5 plasma levels decrease in patients with chronic liver disease (2011) (25)
A positive feedback loop between RIP3 and JNK controls nonalcoholic steatohepatitis (2014) (25)
Treatment for hepatitis B in patients with drug resistance. (2016) (25)
Why high suPAR is not super - diagnostic, prognostic and potential pathogenic properties of a novel biomarker in the ICU (2011) (25)
Relevance of hepatitis B core gene deletions in patients after kidney transplantation. (2003) (25)
Adapted Immune Responses of Myeloid-Derived Cells in Fatty Liver Disease (2018) (25)
Nuclear Receptors Linking Metabolism, Inflammation, and Fibrosis in Nonalcoholic Fatty Liver Disease (2022) (24)
European ‘NAFLD Preparedness Index’ — Is Europe ready to meet the challenge of fatty liver disease? (2021) (24)
Balance of inflammatory pathways and interplay of immune cells in the liver during homeostasis and injury (2014) (24)
S3-Leitlinie der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) zur Prophylaxe, Diagnostik und Therapie der Hepatitis-B-Virusinfektion – (AWMF-Register-Nr. 021-11) (2021) (23)
Inflammation, Hyperglycemia, and Adverse Outcomes in Individuals With Diabetes Mellitus Hospitalized for COVID-19 (2022) (23)
C-terminal proendothelin-1 (CT-proET-1) is associated with organ failure and predicts mortality in critically ill patients (2017) (23)
High Protein Intake Is Associated With Histological Disease Activity in Patients With NAFLD (2020) (23)
Analysis of factors contributing to higher erythropoietin levels in patients with chronic liver disease (2004) (22)
Clinical Practice Guidelines of the European Association for the study of the Liver - Advancing methodology but preserving practicability. (2019) (22)
Molecular and clinical aspects of hepatitis D virus infections. (2012) (22)
Met-CCL5 modifies monocyte subpopulations during liver fibrosis regression. (2013) (22)
Genomic Diversity of Hepatitis B Virus Infection Associated With Fulminant Hepatitis B Development (2015) (22)
Targeting CCR2/5 in the treatment of nonalcoholic steatohepatitis (NASH) and fibrosis: opportunities and challenges (2020) (22)
Enhancing the Efficacy of CAR T Cells in the Tumor Microenvironment of Pancreatic Cancer (2020) (22)
Molecular analysis of an HBsAg-negative hepatitis B virus mutant selected in a tenofovir-treated HIV-hepatitis B virus co-infected patient (2009) (21)
Skeletal Muscle Composition Predicts Outcome in Critically Ill Patients (2020) (21)
Non-canonical HIF-1 stabilization contributes to intestinal tumorigenesis (2019) (21)
CCR8 marks highly suppressive Treg cells within tumours but is dispensable for their accumulation and suppressive function (2021) (21)
Liver function critically determines serum retinol‐binding protein 4 (RBP4) levels in patients with chronic liver disease and cirrhosis (2008) (21)
Liver inflammation and regeneration in drug-induced liver injury: sex matters! (2018) (21)
The co-inhibitory molecule PD-L1 contributes to regulatory T cell-mediated protection in murine crescentic glomerulonephritis (2019) (20)
Inflammatory Mechanisms Underlying Nonalcoholic Steatohepatitis and the Transition to Hepatocellular Carcinoma (2021) (20)
Impact of dexamethasone on SARS-CoV-2 concentration kinetics and antibody response in hospitalized COVID-19 patients: results from a prospective observational study (2021) (20)
High baseline soluble urokinase plasminogen activator receptor (suPAR) serum levels indicate adverse outcome after resection of pancreatic adenocarcinoma (2019) (20)
Bile acid-activated macrophages promote biliary epithelial cell proliferation through integrin αvβ6 upregulation following liver injury. (2021) (20)
The impact of technical and clinical factors on fecal microbiota transfer outcomes for the treatment of recurrent Clostridioides difficile infections in Germany (2019) (20)
Single‐step real‐time PCR to quantify hepatitis B virus and distinguish genotype D from non‐D genotypes (2011) (20)
Plasma P-selectin levels are elevated in patients with chronic liver disease (2003) (20)
Baseline risk factors determine lack of biochemical response after SVR in chronic hepatitis C patients treated with DAAs (2020) (20)
Mass migration to Europe: an opportunity for elimination of hepatitis B virus? (2019) (20)
Beta‐glucosidase 2 knockout mice with increased glucosylceramide show impaired liver regeneration (2012) (20)
The PDE4 inhibitor roflumilast reduces weight gain by increasing energy expenditure and leads to improved glucose metabolism (2017) (20)
Liver fibrosis affects the targeting properties of drug delivery systems to macrophage subsets in vivo. (2019) (19)
Serum levels of soluble urokinase plasminogen activator receptor (suPAR) predict outcome after resection of colorectal liver metastases (2018) (19)
Y-box protein-1/p18 fragment identifies malignancies in patients with chronic liver disease (2011) (19)
[Bleeding origin, patient-related risk factors, and prognostic indicators in patients with acute gastrointestinal hemorrhages requiring intensive care treatment. A retrospective analysis from 1999 to 2010]. (2013) (19)
Clinical and virological characteristics of hospitalised COVID-19 patients in a German tertiary care centre during the first wave of the SARS-CoV-2 pandemic: a prospective observational study (2021) (19)
Molecular interactions between hepatitis B virus and delta virus. (2015) (19)
From proteomic multimarker profiling to interesting proteins: thymosin-β4 and kininogen-1 as new potential biomarkers for inflammatory hepatic lesions (2011) (19)
Cenicriviroc treatment for adults with non-alcoholic steatohepatitis: Year 2 analysis of the Phase 2b CENTAUR study (2018) (19)
Acute hepatitis B virus infection by genotype F despite successful vaccination in an immune-competent German patient. (2007) (19)
HBsAg mutations related to occult hepatitis B virus infection in HIV‐positive patients result in a reduced secretion and conformational changes of HBsAg (2017) (18)
Lessons From Immune Checkpoint Inhibitor Trials in Hepatocellular Carcinoma (2021) (18)
Clinical relevance of copeptin plasma levels as a biomarker of disease severity and mortality in critically ill patients (2018) (18)
Visfatin Serum Levels Predict Mortality in Critically Ill Patients (2018) (18)
Risk stratification and triage in the emergency department: has this become ‘suPAR’ easy? (2012) (17)
Association of serum albumin level with incidence and mortality of overt hepatic encephalopathy in cirrhosis during hospitalization (2019) (17)
Gold Nanocarriers for Macrophage-Targeted Therapy of Human Immunodeficiency Virus. (2017) (17)
Molecular and Cellular Mediators of the Gut-Liver Axis in the Progression of Liver Diseases (2021) (17)
Quantification of hepatic thrombopoietin mRNA transcripts in patients with chronic liver diseases shows maintained gene expression in different etiologies of liver cirrhosis. (2002) (17)
Primary Neuroendocrine Neoplasms of the Breast: Case Series and Literature Review (2020) (16)
Tiny RNA with great effects: miR-155 in alcoholic liver disease. (2016) (16)
IL-23 prevents IL-13-dependent tissue repair associated with Ly6C(lo) monocytes in Entamoeba histolytica-induced liver damage. (2016) (16)
CXCR5 deficiency ameliorates murine lupus (2016) (16)
The role of recipient myosteatosis in graft and patient survival after deceased donor liver transplantation (2021) (16)
Comprehensive analysis of mutations in the hepatitis delta virus genome based on full-length sequencing in a nationwide cohort study and evolutionary pattern during disease progression. (2015) (16)
Impact of direct-acting antiviral therapy on the need for liver transplantation related to hepatitis C in Germany. (2018) (15)
Ursachen, patientenspezifische Risikofaktoren und prognostische Indikatoren bei akuter gastrointestinaler Blutung und intensivmedizinischer Therapieindikation (2013) (15)
Circulating levels of soluble urokinase plasminogen activator receptor predict outcome after resection of biliary tract cancer (2020) (15)
Elevated Serum Levels of Mixed Lineage Kinase Domain-Like Protein Predict Survival of Patients during Intensive Care Unit Treatment (2018) (15)
[Liver fibrosis - pathogenesis and novel therapeutic approaches]. (2010) (15)
Liver Injury and the Macrophage Issue: Molecular and Mechanistic Facts and Their Clinical Relevance (2021) (15)
In Situ Vaccination as a Strategy to Modulate the Immune Microenvironment of Hepatocellular Carcinoma (2021) (15)
Evolving trends in machine liver perfusion: comments on clinical endpoints and selection criteria. (2019) (15)
Serum Levels of TNF Receptor Ligands Are Dysregulated in Sepsis and Predict Mortality in Critically Ill Patients (2016) (15)
The Role of Adipokines as Circulating Biomarkers in Critical Illness and Sepsis (2019) (15)
CX3CR1 Mediates the Development of Monocyte-Derived Dendritic Cells during Hepatic Inflammation (2019) (15)
CXCR5 is critically involved in progression of lupus through regulation of B cell and double‐negative T cell trafficking (2016) (14)
Elevated CTRP1 Plasma Concentration Is Associated with Sepsis and Pre-Existing Type 2 Diabetes Mellitus in Critically Ill Patients (2019) (14)
The arginine methyltransferase PRMT7 promotes extravasation of monocytes resulting in tissue injury in COPD (2022) (14)
Serum sodium based modification of the MELD does not improve prediction of outcome in acute liver failure (2013) (14)
Infiltrating monocytes versus resident kupffer cells: Do alternatively activated macrophages need to be targeted alternatively? (2011) (14)
Circulating Bile Acids in Liver Failure Activate TGR5 and Induce Monocyte Dysfunction (2021) (14)
High mobility group box 1 as a biomarker in critically ill patients (2018) (14)
Liver fibrosis: Which mechanisms matter? (2016) (14)
The clinical relevance of oliguria in the critically ill patient: analysis of a large observational database (2020) (14)
Controversies and Opportunities in the Use of Inflammatory Markers for Diagnosis or Risk Prediction in Fatty Liver Disease (2021) (14)
Identifying High-Risk NASH Patients: What We Know so Far (2020) (14)
Expression of Inducible Bcl-XS in Myeloid Leukemia: Compensatory Upregulation of Bcl-XL and Bcl-2 Prevents Apoptosis and Chemosensitization (2004) (13)
One-Step Fabrication of Biocompatible Multifaceted Nanocomposite Gels and Nanolayers. (2017) (13)
ESA-RANDOMIZED CONTROLLED TRIAL Hypothermic Oxygenated Machine Perfusion Reduces Early Allograft Injury and Improves Post-transplant Outcomes in Extended Criteria Donation Liver Transplantation From Donation After Brain Death Results From a Multicenter Randomized Controlled Trial (HOPE ECD-DBD) (2021) (13)
Differential Gene Expression in Circulating CD14+ Monocytes Indicates the Prognosis of Critically Ill Patients with Sepsis (2020) (13)
Dendritic cells in liver fibrosis: conductor of the inflammatory orchestra? (2010) (13)
Molecular response of liver sinusoidal endothelial cells on hydrogels. (2015) (13)
The Potential Role of Cellular Senescence in Non-Alcoholic Fatty Liver Disease (2022) (13)
Serum NT-proCNP concentrations are elevated in patients with chronic liver diseases and associated with complications and unfavorable prognosis of cirrhosis. (2012) (12)
Deciphering the Immune Microenvironment on A Single Archival Formalin-Fixed Paraffin-Embedded Tissue Section by An Immediately Implementable Multiplex Fluorescence Immunostaining Protocol (2020) (12)
Elevated circulating CD14++CD16+ intermediate monocytes are independently associated with extracardiac complications after cardiac surgery (2020) (12)
Antiviral Therapy in Patients with Viral Hepatitis and Hepatocellular Carcinoma: Indications and Prognosis (2016) (12)
Efficacy of Retreatment After Failed Direct-acting Antiviral Therapy in Patients With HCV Genotype 1-3 Infections. (2019) (12)
Elevated MR-proANP plasma concentrations are associated with sepsis and predict mortality in critically ill patients (2019) (12)
High Prevalence of Sticky Platelet Syndrome in Patients with Infertility and Pregnancy Loss (2019) (12)
Serum concentrations of A Proliferation-Inducing Ligand (APRIL) are elevated in sepsis and predict mortality in critically ill patients. (2013) (12)
The therapeutic landscape of hepatocellular carcinoma. (2021) (12)
Roles of CCR2 and CCR5 for Hepatic Macrophage Polarization in Mice With Liver Parenchymal Cell-Specific NEMO Deletion (2020) (12)
Controlling autophagy: A new concept for clearing liver disease (2011) (12)
Progressive Sarcopenia Correlates with Poor Response and Outcome to Immune Checkpoint Inhibitor Therapy (2021) (12)
Pulmonary Complications in Patients with Liver Cirrhosis (2020) (12)
Recent Advances and the Potential for Clinical Use of Autofluorescence Detection of Extra-Ophthalmic Tissues (2020) (12)
CXCR6 protects from inflammation and fibrosis in NEMOLPC-KO mice. (2019) (12)
miR-155 Predicts Long-Term Mortality in Critically Ill Patients Younger than 65 Years (2019) (11)
Risk of Stroke in Liver Cirrhosis (2020) (11)
Understanding the cellular interactome of non-alcoholic fatty liver disease (2022) (11)
Bile Acids Activate NLRP3 Inflammasome, Promoting Murine Liver Inflammation or Fibrosis in a Cell Type-Specific Manner (2021) (11)
Serum Levels of Kisspeptin Are Elevated in Patients with Pancreatic Cancer (2019) (11)
Akutes Leberversagen (2017) (11)
Clinical relevance of plasma virome dynamics in liver transplant recipients (2020) (11)
Frequency and Phenotype of Human Circulating and Intrahepatic Natural Killer Cell Subsets Is Differentially Regulated according to Stage of Chronic Liver Disease (2013) (11)
BMP feed-forward loop promotes terminal differentiation in gastric glands and is interrupted by H. pylori-driven inflammation (2022) (11)
Models of Gastroenteropancreatic Neuroendocrine Neoplasms: Current Status and Future Directions (2020) (11)
Comparison of gene expression profiles between human and mouse monocyte subsets (Blood (2010) 115, 3 (e10-e19)) (2010) (11)
Circulating Levels of Osteopontin Predict Patients’ Outcome after Resection of Colorectal Liver Metastases (2018) (11)
Combined Therapy with a CCR2/CCR5 Antagonist and FGF21 Analogue Synergizes in Ameliorating Steatohepatitis and Fibrosis (2022) (11)
Intestinal microbiota drives cholestasis-induced specific hepatic gene expression patterns (2021) (11)
Efficient recombinant hepatitis E virus vaccine: Mission accomplished? (2007) (10)
From NAFLD to HCC: Is IL‐17 the crucial link? (2017) (10)
The APAC Score: A Novel and Highly Performant Serological Tool for Early Diagnosis of Hepatocellular Carcinoma in Patients with Liver Cirrhosis (2021) (10)
Elevated Omentin Serum Levels Predict Long-Term Survival in Critically Ill Patients (2016) (10)
The Unexpected Role of Neutrophils for Resolving Liver Inflammation by Transmitting MicroRNA‐223 to Macrophages (2020) (10)
«The times they are a'changin'» - Positioning the European Association for the Study of the Liver in the changing landscape of hepatology. (2018) (10)
An NF-kappaB- and IKK-Independent Function of NEMO Prevents Hepatocarcinogenesis by Suppressing Compensatory Liver Regeneration (2019) (10)
Resolving the fibrotic niche of human liver cirrhosis at single-cell level (2019) (10)
The Dual Ccr2/Ccr5 Antagonist Cenicriviroc Ameliorates Steatohepatitis and Fibrosis in Vivo by Inhibiting the Infiltration of Inflammatory Monocytes into Injured Liver (2016) (10)
[Abnormal liver function tests in the intensive care unit]. (2013) (9)
Endogenous serum levels of thrombopoietic cytokines in healthy whole‐blood and platelet donors: implications for plateletpheresis (1999) (9)
A sustainable development goal framework to guide multisectoral action on NAFLD through a societal approach (2021) (9)
European guideline on obesity care in patients with gastrointestinal and liver diseases – Joint European Society for Clinical Nutrition and Metabolism / United European Gastroenterology guideline (2022) (9)
High Circulating Caspase-Cleaved Keratin 18 Fragments (M30) Indicate Short-Term Mortality in Critically Ill Patients (2018) (9)
Angiotensin‐Converting Enzyme Inhibitors, Angiotensin II Receptor Blockers, and Outcomes in Patients Hospitalized for COVID‐19 (2021) (9)
[Acute liver failure. Diagnosis and therapy]. (2013) (9)
Immune surveillance of liver cancer in non-alcoholic fatty liver disease: excess lipids cause CD4 T-cells loss and promote hepatocellular carcinoma development. (2016) (9)
Circulating levels of microRNA193a-5p predict outcome in early stage hepatocellular carcinoma (2020) (9)
Relevance of Hepatitis B Virus Genome Variability in Organ Transplantation (2007) (9)
Association of Serum Calprotectin Concentrations with Mortality in Critically Ill and Septic Patients (2020) (9)
Aktualisierte S2k-Leitlinie nicht-alkoholische Fettlebererkrankung der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) – April 2022 – AWMF-Registernummer: 021–025 (2022) (9)
Expression of the megalin C-terminal fragment by macrophages during liver fibrogenesis in mice. (2011) (9)
Hepatitis delta virus facilitates the selection of hepatitis B virus mutants in vivo and functionally impacts on their replicative capacity in vitro. (2016) (9)
Serum levels of S100A6 are unaltered in patients with resectable cholangiocarcinoma (2016) (9)
Distinct anti-tumoral functions of adaptive immune cells in liver cancer (2012) (9)
Impact of hepatitis B e antigen‐suppressing mutations on the replication efficiency of entecavir‐resistant hepatitis B virus strains (2011) (8)
Impact of spontaneous splenorenal shunt on liver volume and long‐term survival of liver cirrhosis (2021) (8)
CX3CR1 modulates the anti-inflammatory activity of hepatic dendritic cells in response to acute liver injury. (2017) (8)
Leberwerterhöhung auf der Intensivstation (2013) (8)
How effective are nonalcoholic fatty liver disease models for drug discovery? (2020) (8)
European guideline on obesity care in patients with gastrointestinal and liver diseases - Joint ESPEN/UEG guideline. (2022) (8)
Decreased CTRP3 Plasma Concentrations Are Associated with Sepsis and Predict Mortality in Critically Ill Patients (2019) (8)
Recurrence of Hepatocellular Carcinoma After Liver Transplantation is Associated with Episodes of Acute Rejections (2021) (8)
Repair macrophages in acute liver failure (2017) (8)
Recent Advances in Practical Methods for Liver Cell Biology: A Short Overview (2020) (8)
Spontaneous splenorenal shunt may decrease the long-term survival of liver cirrhosis by compromising liver volume. (2021) (8)
Use of nonselective β blockers after variceal eradication in cirrhotic patients undergoing secondary prophylaxis of esophageal variceal bleeding: a critical review of current evidence (2019) (8)
The Role of Radiologic Modalities in Diagnosing Nonalcoholic Steatohepatitis (NASH) and Fibrosis (2018) (8)
Real-World Clinical Management of Patients with Primary Biliary Cholangitis—A Retrospective Multicenter Study from Germany (2021) (8)
Serum levels of circulating microRNA-107 are elevated in patients with early-stage HCC (2021) (8)
Circulating Osteopontin Levels and Outcomes in Patients Hospitalized for COVID-19 (2021) (8)
PD-L1 – inhibitors in neuroendocrine neoplasia (2021) (8)
The Roles of CXCL16 and CXCR6 in Liver Inflammation and Fibrosis (2015) (8)
Liver Fibrosis—From Mechanisms of Injury to Modulation of Disease (2022) (8)
In Vivo Models for Cholangiocarcinoma—What Can We Learn for Human Disease? (2020) (8)
Relevance of serum sclerostin concentrations in critically ill patients (2017) (8)
Natural history and predictors associated with the evolution of portal venous system thrombosis in liver cirrhosis (2021) (7)
Current Challenges in the Post-Transplant Care of Liver Transplant Recipients in Germany (2020) (7)
Updated epidemiology of hepatitis C virus infections and implications for hepatitis C virus elimination in Germany (2022) (7)
Management der dekompensierten Leberzirrhose auf der Intensivstation (2013) (7)
Responses of gastric epithelial stem cells and their niche to Helicobacter pylori infection (2020) (7)
Erste Daten zur Versorgungssituation von Patienten mit nicht alkoholischer Fettlebererkrankung (NAFLD) in Deutschland – Eine Umfrage an universitären hepatologischen Zentren (2014) (7)
Current status of immunotherapy in gastrointestinal malignancies (2020) (7)
Serum Levels of miR-143 Predict Survival in Critically Ill Patients (2019) (7)
Regulatory T cells and immune tolerance to coagulation factor IX in the context of intramuscular AAV1 gene transfer. (2010) (7)
Hepatitis B e antigen‐suppressing mutations enhance the replication efficiency of adefovir‐resistant hepatitis B virus strains (2013) (7)
Liver impairment in critical illness and sepsis: the dawn of new biomarkers? (2019) (7)
Analysis of miR-29 Serum Levels in Patients with Neuroendocrine Tumors—Results from an Exploratory Study (2020) (7)
Evaluation of Fontan failure by classifying the severity of Fontan-associated liver disease: a single-centre cross-sectional study. (2020) (7)
From Liver Cirrhosis to Cancer: The Role of Micro-RNAs in Hepatocarcinogenesis (2021) (7)
Regeneration in acute-on-chronic liver failure - the phantom lost its camouflage. (2020) (7)
[Management of decompensated liver cirrhosis in the intensive care unit]. (2013) (7)
Serum levels of soluble B and T lymphocyte attenuator predict overall survival in patients undergoing immune checkpoint inhibitor therapy for solid malignancies (2021) (7)
Risk factors for remaining liver injury in patients with virological elimination of chronic hepatitis C (2019) (7)
The Role of Microbiota in Primary Sclerosing Cholangitis and Related Biliary Malignancies (2021) (7)
A Combined Score of Circulating miRNAs Allows Outcome Prediction in Critically Ill Patients (2019) (6)
Synthetic integrin-binding immune stimulators target cancer cells and prevent tumor formation (2017) (6)
Value of magnifying endoscopy in classifying colorectal polyps based on vascular pattern (2009) (6)
HBV Subgenotypes D1, D2, D-del! Are ‘Old‘ Genotyping Methods Interpreted Correctly? (2013) (6)
The Role of miRNA in the Pathophysiology of Neuroendocrine Tumors (2021) (6)
In search of the magic bullet: can liver inflammation and fibrosis be reversed with medications? (2015) (6)
Soluble Urokinase Plasminogen Activator Receptor (suPAR) Concentrations Are Elevated in Patients with Neuroendocrine Malignancies (2020) (6)
Impact of Angiogenesis- and Hypoxia-Associated Polymorphisms on Tumor Recurrence in Patients with Hepatocellular Carcinoma Undergoing Surgical Resection (2020) (6)
Yersinia infection mimicking recurrence of gastrointestinal stromal tumor (2004) (6)
Combined analysis of gut microbiota, diet and PNPLA3 polymorphism in biopsy‐proven non‐alcoholic fatty liver disease (2021) (6)
De Novo Development of Distal Jejunal and Duodenal Adenomas after 41 Months of Teduglutide Treatment in a Short Bowel Patient: A Case Report. (2020) (6)
JNK signaling prevents biliary cyst formation through a CASPASE-8–dependent function of RIPK1 during aging (2021) (6)
Serum Levels of Soluble Urokinase Plasminogen Activator Receptor Predict Tumor Response and Outcome to Immune Checkpoint Inhibitor Therapy (2021) (6)
Minimization of Immunosuppressive Therapy Is Associated with Improved Survival of Liver Transplant Patients with Recurrent Hepatocellular Carcinoma (2021) (6)
Low Myostatin Serum Levels Are Associated with Poor Outcome in Critically Ill Patients (2020) (6)
Outcome of liver cancer patients with SARS‐CoV‐2 infection: An International, Multicentre, Cohort Study (2022) (6)
Combining GP73 with liver stiffness measurements: A proof‐of‐concept for non‐invasive fibrosis assessment in antiviral‐naïve HBV patients (2017) (5)
Diagnostik und Therapie von Clostridium-difficile-Infektionen auf deutschen Intensivstationen – eine Umfrage unter Intensivmedizinern (2018) (5)
Novel findings in an old model: Overexpression of c-myc in hepatocytes promotes the activation of hepatic stellate cells and facilitates the onset of liver fibrosis (2013) (5)
Review article: vascular effects of PPARs in the context of NASH (2022) (5)
Real‐life experiences with bulevirtide for the treatment of hepatitis delta—48 weeks data from a German centre (2022) (5)
Do we still need pharmacological stress ulcer prophylaxis at the ICU? (2017) (5)
Impact of Drug-Resistance Polymerase Mutations on the Replication of HBeAg-Positive and HBeAg-Negative Hepatitis B Virus Strains in Vitro (2012) (5)
Prolonged Survival of a Patient with Advanced-Stage Combined Hepatocellular-Cholangiocarcinoma (2020) (5)
Serum levels of kisspeptin are elevated in critically ill patients (2018) (5)
S1-Leitlinie zur Versorgung von Lebertransplantierten während der COVID-19-Pandemie (2021) (5)
Effective inhibition of glycolysis in venous whole blood and plasma samples (2012) (5)
Targeting and Modulation of Liver Myeloid Immune Cells by Hard‐Shell Microbubbles (2018) (5)
Gastric stem cells promote inflammation and gland remodeling in response to Helicobacter pylori via Rspo3‐Lgr4 axis (2022) (5)
Fibrogenic Pathways in Metabolic Dysfunction Associated Fatty Liver Disease (MAFLD) (2022) (5)
Elevated serum levels of bone sialoprotein during ICU treatment predict long-term mortality in critically ill patients (2018) (5)
Prevention and Management of CMV Infections after Liver Transplantation: Current Practice in German Transplant Centers (2020) (5)
Protective effects of Lipocalin-2 (LCN2) in acute and chronic liver injury indicate a novel function in liver homeostasis (2013) (5)
New Insights on the Role of Kupffer Cells in Liver Transplantation. (2018) (5)
Pathophysiologie der Leberfibrose (2010) (5)
[First data concerning the medical supply of patients with non-alcoholic fatty liver disease in Germany - a survey in university hospital centers of hepatology]. (2015) (5)
The Effects of MELD-Based Liver Allocation on Patient Survival and Waiting List Mortality in a Country with a Low Donation Rate (2020) (5)
Portal fibroblasts with mesenchymal stem cell features form a reservoir of proliferative myofibroblasts in liver fibrosis (2022) (5)
Neutrophil to lymphocyte ratio and albumin-bilirubin score for predicting the in-hospital mortality of hepatocellular carcinoma with acute upper gastrointestinal bleeding (2017) (4)
Genetic Variant of CXCR1 (rs2234671) Associates with Clinical Outcome in Perihilar Cholangiocarcinoma (2022) (4)
Haemorrhagic ulcerative duodenitis in a patient with COVID-19 infection: clinical improvement following treatment with budesonide (2021) (4)
Healing the scars of life-targeting redox imbalance in fibrotic disorders of the elderly. (2015) (4)
Regulation of plasma erythropoietin in chronic liver disease. (2004) (4)
Elevated serum levels of bone sialoprotein (BSP) predict long-term mortality in patients with pancreatic adenocarcinoma (2019) (4)
The socioeconomic aspects of nonalcoholic fatty liver disease: food insecurity as a novel risk factor for steatosis and liver fibrosis. (2020) (4)
Y-box protein–1/p18 fragment identifies malignancies in patients with chronic liver disease (2008) (4)
Safety of transanal ileal pouch-anal anastomosis for ulcerative colitis: a retrospective observational cohort study (2021) (4)
Hepatitis E vaccine: current status and future prospects (2009) (4)
Treating inflammation to combat non-alcoholic fatty liver disease. (2022) (4)
Monocyte dysregulation: consequences for hepatic infections (2021) (4)
[Nutrition Support Therapy in Critically Ill Patients]. (2019) (4)
Rationale of using the dual chemokine receptor CCR2/CCR5 inhibitor cenicriviroc for the treatment of COVID-19 (2022) (4)
Distinct histopathological phenotypes of severe alcoholic hepatitis suggest different mechanisms driving liver injury and failure (2022) (4)
Platform trials to overcome major shortcomings of traditional clinical trials in non-alcoholic steatohepatitis? Pros and Cons. (2022) (4)
Acetyl-CoA Carboxylase Inhibition as a Therapeutic Tool in the Battle Against NASH: Hitting More Than Just One Mechanism? (2020) (4)
Prognostic and Predictive Molecular Markers in Cholangiocarcinoma (2022) (4)
Association of hepatitis B e antigen and DNA viral load with severity of liver dysfunction and in-hospital outcomes in hepatitis B-related liver cirrhosis (2017) (4)
Rituximab-Containing Treatment Regimens May Imply a Long-Term Risk for Difficult-To-Treat Chronic Hepatitis E (2020) (4)
Evaluation of muscarinic acetylcholine receptor type 3 gene polymorphisms in patients with primary biliary cholangitis and primary sclerosing cholangitis (2019) (4)
Effektive Glykolyse-Inhibierung im Citrat-gepufferten venösen Vollblut und Plasma/Effective inhibition of glycolysis in venous whole blood and plasma samples (2012) (4)
Eat more carrots? Dampening cell death in ethanol-induced liver fibrosis by β-carotene. (2013) (4)
Gastrointestinale Blutungen als Komplikation von Patienten mit Leberzirrhose auf der Intensivstation (2013) (4)
Atezolizumab and bevacizumab-induced encephalitis in advanced hepatocellular carcinoma (2021) (4)
Studying metabolism with multi-organ chips: new tools for disease modelling, pharmacokinetics and pharmacodynamics (2022) (4)
Differential Roles of Tumor Necrosis Factor Ligand Superfamily Members as Biomarkers in Pancreatic Cancer (2018) (4)
Hepatic macrophages in liver homeostasis and diseases-diversity, plasticity and therapeutic opportunities (2020) (4)
Serum levels of miR-223 but not miR-21 are decreased in patients with neuroendocrine tumors (2020) (4)
Midregional Proadrenomedullin (MRproADM) Serum Levels in Critically Ill Patients Are Associated with Short-Term and Overall Mortality during a Two-Year Follow-Up (2020) (4)
MAdCAM-1/α4β7 Integrin-Mediated Lymphocyte/Endothelium Interactions Exacerbate Acute Immune-Mediated Hepatitis in Mice (2020) (4)
Platform trials to overcome major shortcomings of traditional clinical trials in non-alcoholic steatohepatitis? Pros and Cons. (2022) (4)
Deep learning can predict microsatellite instability directly from histology in gastrointestinal cancer (2019) (4)
R-spondin/YAP axis promotes gastric oxyntic gland regeneration and Helicobacter pylori–associated metaplasia in mice (2022) (3)
Cyclin E1 in Murine and Human Liver Cancer: A Promising Target for Therapeutic Intervention during Tumour Progression (2021) (3)
Decreased Bone Mineral Density Is a Predictor of Poor Survival in Critically Ill Patients (2021) (3)
Risk Prediction for Acute Kidney Injury - Super Important, Now suPAR Easy? (2020) (3)
Levels of Circulating PD-L1 Are Decreased in Patients with Resectable Cholangiocarcinoma (2021) (3)
Serum Perilipin 2 (PLIN2) Predicts Multiple Organ Dysfunction in Critically Ill Patients (2021) (3)
[The use of immuno-oncologic therapy in hepatocellular carcinoma in the context of liver transplantation. An interdisciplinary benefit/risk assessment]. (2021) (3)
Hepatitis B und D: aktuelle und zukünftige Therapien (2019) (3)
[Acute liver failure]. (2017) (3)
Shear Wave Elastography in the Detection of Sinusoidal Obstruction Syndrome in Adult Patients Undergoing Allogenic Hematopoietic Stem Cell Transplantation (2021) (3)
A rare case of HBV genotype fluctuation (shifting and reversion) after liver transplantation. (2015) (3)
Treatment outcomes of patients with G3 neuroendocrine neoplasms. (2020) (3)
Evolution of Nonmalignant Portal Vein Thrombosis in Liver Cirrhosis: A Pictorial Review (2021) (3)
Serum hepatitis B virus DNA level as a risk predictor for liver disease complications (2006) (3)
Shear wave elastography and shear wave dispersion imaging in primary biliary cholangitis-a pilot study. (2021) (3)
Addition of pegylated interferon alfa-2a to an ongoing nucleos(t) ide treatment accelerates decrease of HBs-antigen levels in patients with chronic hepatitis B: Results from the PADD-ON study (2018) (3)
[Microbiome & NASH - partners in crime driving progression of fatty liver disease]. (2019) (3)
Macrophage migration inhibitory factor predicts an unfavorable outcome after transarterial chemoembolization for hepatic malignancies (2021) (3)
Liver immunology: new perspectives. (2014) (3)
CT-based determination of excessive visceral adipose tissue is associated with an impaired survival in critically ill patients (2021) (3)
Wie lässt sich die Eliminierung von Hepatitis B, C und D in Deutschland messen? Ergebnisse eines interdisziplinären Arbeitstreffens (2020) (3)
Serum levels of bone sialoprotein correlate with portal pressure in patients with liver cirrhosis (2020) (3)
357 - Cenicriviroc Treatment for Adults with Non-Alcoholic Steatohepatitis: Year 2 Analysis of the Phase 2B Centaur Study (2018) (3)
Comparative Analysis of Circulating Biomarkers for Patients Undergoing Resection of Colorectal Liver Metastases (2021) (3)
Interleukin-18 signaling promotes activation of hepatic stellate cells in murine liver fibrosis. (2022) (3)
Hepatic fibrosis is associated with histological activity in nonalcoholic steatohepatitis: an analysis from a large database of screening biopsies in the CENTAUR trial (2017) (3)
A rare case of a patient with a high grade neuroendocrine tumor developing neutropenic sepsis after receiving PRRT combined with Capecitabine or Temozolomide: A case report (2020) (3)
Leberfunktionsstörungen bei Sepsis (2020) (3)
Outcomes of Liver Resections after Liver Transplantation at a High-Volume Hepatobiliary Center (2020) (3)
73 TAK1 SUPPRESSES A NEMO-DEPENDENT, BUT NF-KAPPAB-INDEPENDENT PATHWAY TO LIVER CANCER (2010) (3)
Correction to: Neutrophils are a main source of circulating suPAR predicting outcome in critical illness (2019) (3)
A liver nodule in a patient transplanted for primary sclerosing cholangitis: an interdisciplinary diagnostic approach (2016) (3)
Location, location, location — spatial insight into hepatic macrophage populations (2022) (3)
Akutes Leberversagen (2017) (3)
Telomere Shortening in Peripheral Leukocytes Is Associated With Poor Survival in Cancer Patients Treated With Immune Checkpoint Inhibitor Therapy (2021) (3)
Monozyten-Subpopulationen in Entzündungsprozessen: Prinzip und Perspektive (2009) (3)
[Diagnosis and stage-adapted treatment of acute pancreatitis]. (2018) (3)
Dekompensierte Leberzirrhose und akut-auf-chronisches Leberversagen (2020) (2)
Hepatitis B goes globe: Telbivudine as a new treatment option (2008) (2)
S1-Leitlinie zur Versorgung von Lebertransplantierten während der COVID-19-Pandemie – AWMF-Register Nr. 021-031 – Stand: 07.01.21 (2021) (2)
Use of Human Albumin Administration for the Prevention and Treatment of Hyponatremia in Patients with Liver Cirrhosis: A Systematic Review and Meta-Analysis (2022) (2)
Elevated liver enzymes predict morbidity and mortality despite antiviral cure in patients with chronic hepatitis C: Data from the German Hepatitis C‐Registry (2022) (2)
Hepatische Dysfunktion bei Patienten mit kardiogenem Schock (2019) (2)
Acute liver injury following acetaminophen administration does not activate atrophic pathways in the mouse diaphragm (2021) (2)
Ex vivo liver machine perfusion: comprehensive review of common animal models. (2022) (2)
Mapping the hepatic immune landscape identifies monocytic macrophages as key drivers of steatohepatitis and cholangiopathy progression. (2023) (2)
Polymere Selectinliganden als komplexe Glykomimetika: von Selectinbindung bis zur Modifizierung der Makrophagenmigration (2017) (2)
Single Cell RNA Sequencing in NASH. (2022) (2)
S1-Leitlinie zur Versorgung von Lebertransplantierten während der COVID-19-Pandemie – AWMF-Registernummer: 021-031 – Stand 15. Juni 2022 (2022) (2)
O033 : CCR2+ infiltrating monocytes promote acetaminophen-induced acute liver injury – therapeutic implications of inhibiting CCR2 and CCL2 (2015) (2)
Many roads lead to Rome: The FGF4–AMP‐activated protein kinase–Caspase 6 signal axis in NAFLD and NASH (2022) (2)
Clinical utility of quantifying hepatitis B surface antigen in African patients with chronic hepatitis B (2021) (2)
Authors' response: impact of renal replacement therapy on osteopontin levels in critically ill patients. (2015) (2)
Non-canonical HIF-1 stabilization is essential for intestinal tumorigenesis (2018) (2)
Macrophages in cholangiopathies (2021) (2)
The Multifaceted Roles of Macrophages in NAFLD Pathogenesis (2023) (2)
The macrophage-associated microRNA-4715-3p / Gasdermin D axis potentially indicates fibrosis progression in nonalcoholic fatty liver disease: evidence from transcriptome and biological data (2022) (2)
Targeted Modulation of Macrophage Functionality by Nanotheranostics in Inflammatory Liver Disease and Cancer (2017) (2)
Prevalence and in-hospital outcomes of diabetes mellitus in elderly patients with liver cirrhosis (2017) (2)
Selection of the highly replicative and partially multidrug resistant rtS 78 T polymerase mutation in two patients with chronic hepatitis B virus infection during tenofovir-entecavir combination therapy (2017) (2)
Erythropoietin plasma levels are elevated in chronic liver disease and correlate with anemia, liver dysfunction, bleeding episodes and interleukin-6 (2002) (2)
[Monocyte subpopulations in inflammation processes: principles and perspectives]. (2009) (2)
Publisher Correction: Inhibition of LTβR signalling activates WNT-induced regeneration in lung (2020) (2)
[Consciousness disorders from toxicological view]. (2016) (2)
Variceal bleeding in liver cirrhosis at the ICU: sufficient data to treat adrenal insufficiency?*. (2014) (2)
[Hepatic dysfunction in sepsis]. (2020) (2)
Treatment of Anti-HLA Donor-Specific Antibodies Results in Increased Infectious Complications and Impairs Survival after Liver Transplantation (2020) (2)
Distribution of gastrointestinal neuroendocrine tumors in Europe: results from a retrospective cross-sectional study (2022) (2)
How effective and how durable is DAA‐therapy in HCV‐infected drug users? (2019) (2)
Thyroid hormones as a disease modifier and therapeutic target in nonalcoholic steatohepatitis (2022) (2)
BIOMARKERS OF INFLAMMATION AND OUTCOMES OF PATIENTS HOSPITALIZED FOR COVID-19: THE INTERNATIONAL STUDY OF INFLAMMATION IN COVID-19 (2021) (2)
Treatment of HCV Genotype 2 with Sofosbuvir and Ribavirin Results in Low SVR Rates ina Real World Cohort (German Hepatitis C-Registry, DHC-R) (2016) (2)
Non-invasive assessment for alpha-1 antitrypsin deficiency-associated liver disease: new insights on steatosis and fibrosis in Pi*ZZ carriers. (2019) (2)
[Gastrointestinal bleeding in liver cirrhosis at the ICU]. (2013) (2)
[Management of Clostridium difficile infections at German intensive care units - results from a survey among intensivists]. (2018) (2)
Small heterodimer partner (SHP) links hepatitis C and liver fibrosis: a small protein on the big stage (2015) (2)
Ferroptosis in Cancer Immunotherapy—Implications for Hepatocellular Carcinoma (2022) (2)
Donor-Specific Antibodies Against Donor Human Leukocyte Antigen are Associated with Graft Inflammation but Not with Fibrosis Long-Term After Liver Transplantation: An Analysis of Protocol Biopsies (2021) (2)
Bulevirtide treatment of hepatitis D in Germany: multicentre real-world experience (2022) (2)
Temporal changes in the epidemiology, management, and outcome from acute respiratory distress syndrome in European intensive care units: a comparison of two large cohorts (2021) (2)
Cytokines in Steatohepatitis (2017) (2)
Low Serum Levels of Soluble Receptor Activator of Nuclear Factor κ B Ligand (sRANKL) Are Associated with Metabolic Dysregulation and Predict Long-Term Mortality in Critically Ill Patients (2021) (1)
Biomarker and Therapeutic Potential of CSF1 in Acute Liver Failure. (2015) (1)
Platelet GPIbα is a mediator and potential interventional target for NASH and subsequent liver cancer (2019) (1)
Enhanced expression of c-myc in hepatocytes promotes initiation and progression of alcoholic liver disease (2015) (1)
[247] CIRCULATING RETINOL BINDING PROTEIN 4 IS REDUCED IN LIVER CIRRHOSIS AND NOT ASSOCIATED WITH INSULIN RESISTANCE (2007) (1)
From the Editor's Desk…. (2021) (1)
Immature neutrophils bring anti-PD-1 therapy in NASH-HCC to maturity (2022) (1)
Pharmacotherapy Profiles in People with Opioid Use Disorders: Considerations for Relevant Drug–Drug Interactions with Antiviral Treatments for Hepatitis C (2021) (1)
Assessing Non-Invasive Liver Function in Patients with Intestinal Failure Receiving Total Parenteral Nutrition—Results from the Prospective PNLiver Trial (2020) (1)
918 ACUTE LIVER FAILURE IN GERMANY 2008-2009: A RETROSPECTIVE ANALYSIS BY THE ACUTE LIVER FAILURE STUDY GROUP GERMANY (2011) (1)
High prevalence of Y-box protein-1/p18 fragment in plasma of patients with malignancies of different origin (2014) (1)
The prognostic impact of preoperative body composition in perihilar and intrahepatic cholangiocarcinoma (2022) (1)
Morphologic Alterations Precede Functional Hepatic Impairment as Determined by 13C-Methacetin Liver Function Breath Test in Adult Fontan Patients (2021) (1)
[Current and Future Therapy of Hepatitis B and D]. (2019) (1)
A case report of an excellent response to interferon- α in a patient with functional metastasized neuroendocrine tumor refractory to other treatments (2020) (1)
Elevated Flt3L Predicts Long-Term Survival in Patients with High-Grade Gastroenteropancreatic Neuroendocrine Neoplasms (2021) (1)
O070 : CX3CR1 is a gatekeeper for intestinal barrier integrity: Limiting steatohepatitis by promoting intestinal homeostasis (2015) (1)
969 CYCLIN E1 CONTROLS THE CELL CYCLE ACTIVITY OF HEPATIC STELLATE CELLS AND TRIGGERS FIBROGENESIS IN MICE (2010) (1)
Add on Interferon-Alpha-2a for the treatment of hbeag negative Hepatitis B patients receiving effective nucleos (t)ide therapy: interim results of the prospective multicentre padd-on trial (2016) (1)
Die Virusreplikation Lamivudin-resistenter Hepatitis B Virus Mutanten wird durch Basale Core Promoter- und Precore-Mutationen erhöht (2004) (1)
The contradictory roles of macrophages in non-alcoholic fatty liver disease and primary liver cancer—Challenges and opportunities (2023) (1)
Shear Wave Elastography and Shear Wave Dispersion Imaging in the Assessment of Liver Disease in Alpha1-Antitrypsin Deficiency (2021) (1)
Severe hepatitis outbreak in children linked to AAV2 virus. (2023) (1)
Adipocytokines in Severe Sepsis and Septic Shock (2011) (1)
229 The fat-derived hormone adiponectin is elevated in patients with chronic liver disease and accumulates in cholestasis (2004) (1)
Liver Transplantation and the Use of Metamizole to Treat Drug-induced Liver Injury. (2022) (1)
p18(INK4c) expression in hepatocellular carcinoma (2005) (1)
Soluble Urokinase Plasminogen Activator Receptor and Venous Thromboembolism in COVID‐19 (2022) (1)
Pharmacological inhibition of the medium chain fatty acid receptor GPR84 reduces myeloid cell in filtration into injured liver and ameliorates steatohepatitis and fibrosis (2018) (1)
Immune Regulatory 1 Cells: A Novel and Potent Subset of Human T Regulatory Cells (2022) (1)
Basale Core Promoter und Precore Mutationen im Hepatitis B Virus Genom steigern die Virusreplikation von Lamivudin-resistenten Mutanten (2004) (1)
Baseline risk factors determine lack of biochemical response after SVR in chronic hepatitis C treated with DAAs – Results from the German Hepatitis C-Registry (DHC-R) (2019) (1)
Long-term persistence of HCV resistance-associated substitutions after DAA treatment failure. (2022) (1)
A Reduction of Calcineurin Inhibitors May Improve Survival in Patients with De Novo Colorectal Cancer after Liver Transplantation (2022) (1)
P93CCL18 aggravates atherosclerosis by inducing CCR6-, not CCR3-, dependent T cell influx and polarization (2014) (1)
The role of the IL6/gp130 system for liver disease progression (2002) (1)
SFB/TRR 57 Aachen/Bonn: Organfibrose – von den Mechanismen der Schädigung zur Beeinflussung der Krankheit (2017) (1)
621 INTERLEUKIN-8 (IL-8) AND IL-8 RELATED PATHWAYS ARE ACTIVATED IN CHRONIC LIVER DISEASE DEPENDENT ON DISEASE SEVERITY AND ETIOLOGY OF CIRRHOSIS (2011) (1)
S2k-Leitlinie nicht alkoholische Fettlebererkrankungen (2015) (1)
Which is the IDEAL Peginterferon for Hepatitis C: A Meta-Analysis of both Pegylated Interferons in the Treatment of HCV-Infected Patients (2010) (1)
Neonatal Peyer’s patch cDC activation as a pacemaker of postnatal immune maturation (2022) (1)
Sofosbuvir für Hepatitis C – Liegt die Würze in der Kürze? (2013) (1)
Effektive Glykolyse-Inhibierung in venösem Vollblut durch Azidifikation des Fluorid Additivs (2012) (1)
The human long noncoding RNAs CoroMarker, MALAT1, CDR1as, and LINC00460 in whole blood of individuals after controlled short-term exposure with ultrafine metal fume particles at workplace conditions, and in human macrophages in vitro (2022) (1)
Long-term results of teduglutide treatment for chronic intestinal failure - Insights from a national, multi-centric patient home-care service program. (2022) (1)
Causes of death in hepatitis B and/or C virus infected–people—lessons for clinical practice (2007) (1)
Hepatische Dysfunktion bei Patienten mit kardiogenem Schock (2020) (1)
Dietary omega-6/omega-3 ratio is not associated with gut microbiota composition and disease severity in patients with nonalcoholic fatty liver disease. (2022) (1)
Soluble urokinase plasminogen activator receptor (suPAR): Its relation to neurological outcome in patients with survived cardiac arrest (2016) (1)
Akutes Leberversagen (2013) (1)
Current epidemiological trends and in-hospital mortality of acute pancreatitis in Germany: a systematic analysis of standardized hospital discharge data between 2008 and 2017 (2021) (1)
Soluble Urokinase Plasminogen Activator Receptor Levels Are Associated with Severity of Fibrosis in Patients with Primary Sclerosing Cholangitis (2022) (1)
Behandlung chronisch entzündlicher Darmerkrankungen in der Intensivmedizin (2012) (1)
P236 RIP3-DEPENDENT NECROPTOSIS CONTROLS NON-ALCOHOLIC STEATOHEPATITIS INDUCED LIVER FIBROSIS VIA JNK (2014) (1)
Targeting liver inflammation using Mincle-targeted liposomes as a novel drug delivery system (2017) (1)
Therapie der Hepatitis-B- und -C-Virusinfektion (2003) (1)
Shear wave elastography-based liver fibrosis assessment in patients with chronic hepatitis E displays elevated liver stiffness regardless of previous antiviral therapy. (2021) (1)
PS-007-Differential therapeutic effects of pan- and single PPAR agonists on steatosis, inflammation, macrophage composition and fibrosis in a murine model of non-alcoholic steatohepatitis (2019) (1)
[Treatment of inflammatory bowel disease in intensive care medicine]. (2012) (1)
Clusterin Plasma Concentrations Are Decreased in Sepsis and Inversely Correlated with Established Markers of Inflammation (2022) (1)
Plateletpheresis does not lead to a lasting increase in serum thrombopoiesis growth factor levels (1999) (1)
[Sofosbuvir for hepatitis C - is brevity the soul of wit?]. (2013) (1)
Leitlinienreport der aktualisierten S2k-Leitlinie nicht-alkoholische Fettlebererkrankung der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) (2022) (1)
Aktuelle Diagnostik und Therapie der Hepatitis B (2005) (1)
Aktuelle Diagnostik und Therapie der Hepatitis B (CME-Fragen) (2005) (1)
The Diagnostic Approach towards Combined Hepatocellular-Cholangiocarcinoma—State of the Art and Future Perspectives (2023) (1)
550 HEPATITIS B VIRUS MUTANTS WITH TENOFOVIR DRUG RESISTANCE HAVE IMPAIRED REPLICATION EFFICIENCIES, WHICH CAN BE RESTORED BY ADDITIONAL PRECORE OR BASIC CORE PROMOTER MUTATIONS (2008) (1)
Editorial: Overcoming the Immune Microenvironment of Hepatocellular Cancer (2021) (1)
Posters02a. Cirrhosis and its Complications: Pathophysiology601 miR-133a MEDIATES TGF-b-DEPENDENT DE-REPRESSION OF COLLAGEN-SYNTHESIS IN HEPATIC STELLATE CELLS DURING LIVER FIBROSIS (2013) (1)
559 PREVALENCE, VIRAL REPLICATION EFFICIENCY AND DRUG SENSITIVITY TOWARDS ADEFOVIR OF Q215 POLYMERASE MUTATIONS IN THE HEPATITIS B VIRUS GENOME (2009) (1)
In Vitro Models for the Study of Liver Biology and Diseases: Advances and Limitations (2022) (1)
HEP-14-1064 CREM α overexpression impairs function of hepatic myeloid derived suppressor cells and aggravates immune-mediated hepatitis in mice (2014) (1)
Modulating Myeloid Immune Cell Migration Using Multivalently Presented Monosaccharide Ligands for Advanced Immunotherapy (2019) (1)
Plateletpheresis does not lead to a lasting increase in serum thrombopoiesis growth factor levels (1999) (1)
REVIEWS IN BASIC AND CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2014) (1)
monocyte subsets Comparison of gene expression profiles between human and mouse (2009) (1)
The Role of Immunosuppression for Recurrent Cholangiocellular Carcinoma after Liver Transplantation (2022) (1)
[The beginning of the end for interferon therapy? - novel interferon-free treatment options for hepatitis C]. (2014) (1)
360 EFFECTS OF NANOROD-CONJUGATED PEPTIDES FOR CELL TARGETING OF HEPATIC MACROPHAGES IN ACUTE AND CHRONIC MURINE LIVER INJURY (2012) (1)
Die pharmakologische Inhibierung des Chemokins CXCL16 hemmt die Makrophagen Infiltration und Steatohepatitis in der chronischen Leberentzündung (2014) (0)
763 THE HEPATIC ACUTE PHASE RESPONSE CONTROLS INFLAMMATION BY PROMOTING MYELOID DERIVED SUPPRESSOR CELL FUNCTIONS IN SEPSIS (2009) (0)
Cenicriviroc Lacked Efficacy to Treat Liver Fibrosis in Nonalcoholic Steatohepatitis: AURORA Phase III Randomized Study. (2023) (0)
Bacterial and Sterile Inflammation In Vivo YB-1 Is an Early and Central Mediator of (2013) (0)
Evaluation of Enzymatic Liver Function Using Liver Maximum Capacity Test (LiMAx) in Adult Fontan Patients (2022) (0)
Author Correction: Auto-aggressive CXCR6+ CD8 T cells cause liver immune pathology in NASH (2021) (0)
577 EVOLUTION OF NATURALLY OCCURRING HEPATITIS B VIRUS TEST AND IMMUNE ESCAPE MUTATIONS FACILITATING PERSISTENCE AND SYMPTOMATIC VIRAL FLARE (2008) (0)
550 REPLICATIVE CAPACITY OF ENTECAVIR-RESISTANT HEPATITIS B VIRUS MUTANTS IN HBeAg-NEGATIVE HEPATITIS B (2009) (0)
The co-inhibitory molecule PD-L1 contributes to regulatory T cell-mediated protection in murine crescentic glomerulonephritis (2019) (0)
Elevated soluble urokinase plasminogen activator receptor serum levels indicate poor survival following transarterial chemoembolization therapy for hepatic malignancies: An exploratory analysis (2021) (0)
MCP-1 dependent balance of inflammatory pathways and interplay of immune cells in the liver during injury, fibrosis and injury regression (2015) (0)
Scheduled Regular Endoscopic Interventions for Patients with Primary Sclerosing Cholangitis Improve Transplant-Free Survival (2023) (0)
935 OVEREXPRESSION OF CREM ALPHA IN CD4+ T CELLS ACCELERATES ACUTE ConA-INDUCED HEPATITIS BUT DOES NOT INFLUENCE FIBROSIS (2013) (0)
IKKALPHA/Beta Regulate Hepatocarcinogenesis and Biliary Homeostasis by Controlling RIPK1 Activity (2016) (0)
From the Editor’s Desk… (2021) (0)
P803 PHARMACOLOGICAL INHIBITION OF THE CHEMOKINE CXCL16 DIMINISHES LIVER MACROPHAGE INFILTRATION AND STEATOHEPATITIS IN CHRONIC HEPATIC INJURY (2014) (0)
The chemokine receptor CCR8 critically controls hepatic macrophage migration and differentiation in murine liver fibrosis (2012) (0)
Next-generation imaging: New insights from multicolor microscopy in liver biology and disease (2021) (0)
The incretin hormone GIP is modulated by inflammatory stimuli and downregulated in critically ill ICU patients: central relevance of interleukin 1 beta (2015) (0)
From the Editor's Desk... (2023) (0)
LETTER TO THE EDITOR: Associations between Hepatitis B Virus Core Gene Mutations, Immune Escape and Clinical Presentation (2013) (0)
A complex triad determining metabolic health: diet, host, and microbiome interaction (2022) (0)
Clinical Practice Guidelines EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection q European Association for the Study of the Liver (2017) (0)
999 HUMAN MONOCYTE SUBSETS ACCUMULATE INTRAHEPATICALLY IN LIVER CIRRHOSIS AND DIFFERENTIALLY INTERACT WITH HEPATIC STELLATE CELLS (2010) (0)
Biomarkers and Liver Disease: Can We Predict Decompensation with suPAR? (2017) (0)
Promotion of macrophage activation and inflammation in chronic liver disease by the histidine-rich glycoprotein (2015) (0)
Editorial: prevalence, progression rates and mortality predictors of non‐alcoholic fatty liver disease reflected by German statutory health insurance data (2020) (0)
The incretin hormone GLP-2 is secreted from pancreatic alpha cells during acute inflammation through IL-6 and protects against polymicrobial sepsis (2018) (0)
Intratumoral dendritic cells and T cells predict survival in gastroenteropancreatic neuroendocrine neoplasms. (2023) (0)
1027 COMPARTMENTAL REGULATION OF suPAR IN PATIENTS WITH DECOMPENSATED CIRRHOSIS: EVALUATION OF ORIGIN, REGULATION AND PROGNOSTIC RELEVANCE (2013) (0)
Tract Infection for Bladder Infiltration in Bacterial Urinary from the Bone Marrow, but Is Dispensable Monocytes high Inflammatory Release of Gr1 CCR2 Mediates Homeostatic and (2008) (0)
CCR2 does not contribute to liver extravasation of CD11b+Ly6C+ monocytic cells during T. brucei infection. (2013) (0)
Virushepatitis: Chronische Hepatitis-B- und -D-Infektion (2020) (0)
GLP-2 as an indicator and modulator of acute inflammation improves cardiac function and survival in sepsis (2022) (0)
LETTER TO EDITOR: WHICH IS THE IDEAL PEGINTERFERON FOR HEPATITIS C: A META-ANALYSIS OF BOTH PEGYLATED INTERFERONS IN THE TREATMENT OF HCV-INFECTED PATIENTS (2010) (0)
Inflammation and Liver Fibrosis Hepatic NK T Cell Accumulation Promotes Chemokine Receptor CXCR6-Dependent (2013) (0)
Treating hepatitis D with bulevirtide - Real-world experience from 114 patients. (2023) (0)
From the Editor's Desk…. (2020) (0)
Critically Ill Patients and Circulating Amino-Terminal Pro-C-Type Natriuretic Peptide (2014) (0)
23 THE SCAVENGER RECEPTOR D6 MODULATES INFLAMMATION DURING LIVER INJURY BY DEGRADATION OF INFLAMMATORY CC CHEMOKINES (2009) (0)
From the Editor's Desk (1957) (0)
Dendritic Cells and Encephalomyelitis Induced by Monocytes A Novel Model of Demyelinating (2006) (0)
Results From Multicenter Sars-Cov-2 Antibody Prevalence Study In Patients With Short Bowel Syndrome In Germany (2023) (0)
From the Editor's Desk... (2020) (0)
Contents (2020) (0)
Dendritic Cell Populations Pulmonary - and CD103 + Rise to CD103 Blood Monocyte Subsets Differentially Give (2017) (0)
Guidelines on the management of hepatitis B virus infection q European Association for the Study of the Liver (2017) (0)
MOESM1 of Serum levels of S100A6 are unaltered in patients with resectable cholangiocarcinoma (2016) (0)
Contents (2020) (0)
Global microRNA profiling reveals complex interactions among hepatic microRNA regulation, hepatitis C virus infection and interferon response (2013) (0)
From the Editor's Desk…. (2020) (0)
P051: HBV genotype fluctuation (shifting and reversion) after liver transplantation (2015) (0)
From the Editor's Desk... (2022) (0)
Variables associated with persistence of elevated ALT after SVR in patients with chronic hepatitis C: Data from the German Hepatitis C-Registry (DHC-R) (2018) (0)
Liposome delivery of M2-polarizing compounds to primary human macrophages for chronil wound healing (2018) (0)
From the Editor's Desk…. (2020) (0)
Platelet counts as predictors of short- and long-term outcomes in liver transplantation: cassandras or just rats on a sinking ship? (2018) (0)
Response to the "Letter to the editor regarding article, 'High‐mobility group box 1 as a biomarker in critically ill patients'.” (2018) (0)
[Liver dysfunction in geriatric patients]. (2022) (0)
From the Editor’s Desk… (2001) (0)
163 THE CHEMOKINE RECEPTOR CXCR3 IS PROTECTIVE DURING ACUTE CCL4 INDUCED LIVER INJURY (2008) (0)
[The Gastrointestinal Tract in Intensive Care Medicine - Overview 2020]. (2020) (0)
Practical guideline on obesity care in patients with gastrointestinal and liver diseases - Joint ESPEN/UEG guideline. (2023) (0)
Teduglutide therapy optimization through continuous oral nutrition counselling in chronic intestinal failure patients (2023) (0)
Quality of Life in Teduglutide-Treated Patients with Short Bowel Syndrome Intestinal Failure—A Nested Matched Pair Real-World Study (2023) (0)
Hepatic C-X-C chemokine receptor type 6-expressing innate lymphocytes limit detrimental myeloid hyperactivation in acute liver injury. (2023) (0)
Liver inflammation abrogates T cell mediated tolerance against particulate antigens induced by liver Kupffer cells (2015) (0)
From the Editor's desk…. (2021) (0)
[Intersectoral management of patients with abnormal liver enzymes and non-alcoholic fatty liver disease (NAFLD)]. (2023) (0)
Lipocalin-2 (LCN2) in experimental liver injury and human liver diseases (2011) (0)
Elevated MR-proANP plasma concentrations are associated with sepsis and predict mortality in critically ill patients (2019) (0)
From the Editor's Desk... (2022) (0)
Author Correction: Platelet GPIbα is a mediator and potential interventional target for NASH and subsequent liver cancer (2022) (0)
A reply to Siciliano et al. (2005) (0)
Contents Vol. 83, 2011 (2011) (0)
Polypharmacy and prevalence of multi drug-drug interactions in hepatitis C patients treated with pangenotypic direct acting antivirals: an analysis from three European countries (2022) (0)
From the Editor’s Desk… (2020) (0)
775 THE NON-CLASSICAL CD14+CD16+ MONOCYTE SUBPOPULATION INCREASES WITH LIVER FIBROSIS AND DISEASE PROGRESSION IN PATIENTS WITH CHRONIC LIVER DISEASES (2009) (0)
From the Editor's Desk... (2020) (0)
Epidemiology and High Rate of Procedure-Related In-Hospital Complications of Chronic Liver Disease in Germany (2022) (0)
130 CASPASE-8 ABLATION RESCUES SPONTANEOUS APOPTOSIS AND HEPATOCARCINOGENESIS IN NEMO-DEFICIENT MICE BUT TRIGGERS NON-APOPTOTIC LIVER INJURY (2011) (0)
Elevated serum levels of bone sialoprotein during ICU treatment predict long-term mortality in critically ill patients (2018) (0)
Targeting liver inflammation using CD64-targeted lipid nanoparticles as a novel drug delivery system (2018) (0)
906 Role of the CCAAT/enhancer binding protein beta (C/EBPB) isoforms lap and lip in liver regeneration (2003) (0)
Predicting survival after TIPS: Child Pugh Score is not inferior to MELD and FIPS Score - back to basics? (2021) (0)
[Treatment of hepatitis B and C virus infection]. (2003) (0)
[The gut-liver axis: how the gut promotes liver disease]. (2022) (0)
P0493 : Selectin-targeting nanoparticles for immunomodulatory therapy of liver diseases (2015) (0)
The heart failure marker TWEAK predicts survival in critically ill patients (2016) (0)
Publisher Correction: Inhibition of LTβR signalling activates WNT-induced regeneration in lung (2020) (0)
CXCR6-dependent hepatic iNKT cells limit hepatocarcinogenesis in vivo by promoting clearance of senescent hepatocytes (2017) (0)
From the Editor's Desk... (2022) (0)
629 IMMUNE ESCAPE MUTATIONS G145R AND P120T DIFFERENTIALLY IMPACT THE REPLICATION EFFICIENCY OF LAMIVUDINE-RESISTANT HEPATITIS B VIRUS E ANTIGEN-POSITIVE AND -NEGATIVE STRAINS (2010) (0)
CCL2-dependent monocyte recruitment contributes to a tumor-promoting microenvironment in a combined fibrosis-HCC model (2017) (0)
Corrigendum to “Factor VII activating protease (FSAP) exerts anti-inflammatory and anti-fibrotic effects in liver fibrosis in mice and men” [J Hepatol 2013;58:104–111] (2014) (0)
199 Impaired pulmonary function in liver cirrhosis is a relevant factor for elevated erythropoietin levels in patients with chronic liver disease (2004) (0)
Evaluation of an automated hyaluronan latex agglutination assay enables the implementation of routine laboratory HEPASCORE calculation (2013) (0)
From the Editor's Desk... (2022) (0)
[Gastrointestinal motility disorders in critically ill patients]. (2022) (0)
[Current Developments in Nutritional Therapy of Intensive Care Patients]. (2018) (0)
Plasmapheresis seems to be beneficial in acute Liver Failure (2017) (0)
From the Editor's Desk... (2022) (0)
Microbubbles as used for contrast-enhanced ultrasound affect the migration of human primary leukocytes (2015) (0)
P0448 : Benefits of isolating HSC using fluorescence-based cell sorting (2015) (0)
PS-004-Western diet triggers a unique inflammatory phenotype of myeloid leukocytes in bone marrow and liver (2019) (0)
From the Editor's Desk… (2020) (0)
From the Editor's Desk... (2023) (0)
Endovascular Occlusion of a Surgical High-Flow Portocaval Shunt Combined with Transjugular Intrahepatic Portosystemic Shunt. (2022) (0)
Hepatic Energy Metabolism under the Local Control of the Thyroid Hormone System (2023) (0)
The chemokine receptor CXCR3 regulates NK and NKT cell recruitment during acute liver injury (2008) (0)
Non-alcoholic fatty liver disease (NAFLD)/non-alcoholic steatohepatitis (NASH) is associated with worse outcomes in patients hospitalised for COVID-19: a real-world analysis of a large population from the premier healthcare database (2022) (0)
Unboxing the cell-type specific contribution of endoplasmic reticulum stress to NASH pathophysiology—myeloid X-box-binding protein 1 as a driver of steatohepatitis and fibrosis (2021) (0)
[IL-6 dependent GLP-1 secretion during acute inflammation]. (2015) (0)
Impact of hepatitis B virus core gene deletions in patients after kidney transplantation on viral replication and disease progression (2003) (0)
Functional hepatic deterioration determined by 13C-methacetin breath test is associated with impaired hemodynamics and late Fontan failure in adults (2022) (0)
From the Editor's Desk…. (2021) (0)
NEMO prevents hepatocarcinogenesis independently of an IKK complex function by controlling liver regeneration (2020) (0)
Transanal Ileal Pouch-Anal Anastomosis for Ulcerative Colitis - A Retrospective Single-Center Study Regarding Anastomotic Leakage and Episodes of Pouchitis in the Long-Term (2021) (0)
Supplementary Material 18 (2014) (0)
The role of histidine-rich glycoprotein in non alcoholic steatohepatitis-related experimental liver carcinogenesis (2022) (0)
9 Adipocytokines in Severe Sepsis and Septic Shock (2017) (0)
M cell maturation and cDC activation determine the onset of adaptive immune priming in the neonatal Peyer's patch. (2023) (0)
CX3CR1 modulates the differentiation of monocyte-derived inflammatory dendritic cells in response to hepatic injury (2017) (0)
[Management of acutely decompensated liver cirrhosis in emergency and critical care medicine]. (2022) (0)
Elevated serum levels of bone sialoprotein (BSP) predict long-term mortality in patients with pancreatic adenocarcinoma (2019) (0)
The Secretion of Endocrine in Hormone GIP is regulated by inflammatory Stimuli in Interleukin-1-dependent and is greatly reduced in critically ill ICU Patients (2015) (0)
Differentiation, activation and function of CD11b+Ly6C+TNF/iNOS-producing dendritic cells during parasitic infection (2009) (0)
Erratum: Hohlstein, P. et al. Prognostic Relevance of Altered Lymphocyte Subpopulations in Critical Illness and Sepsis. Journal of Clinical Medicine 2019, 8, 353 (2019) (0)
P391 CD2-SPECIFIC OVEREXPRESSION OF CREM ALPHA AGGRAVATES ACUTE CONCANAVALIN A-INDUCED HEPATITIS (2014) (0)
From the Editor's Desk…. (2022) (0)
Reply: To PMID 24481979. (2014) (0)
CCR6 Deficiency Increases Infarct Size after Murine Acute Myocardial Infarction (2021) (0)
Hepatobiliary long-term consequences of COVID-19: dramatically increased rate of secondary sclerosing cholangitis in critically ill COVID-19 patients (2023) (0)
The scavenger receptor D6 limits acute liver damage by degradation of inflammatory chemokines after injury (2009) (0)
SAT-470-Circulating levels of soluble urokinase plasminogen activator receptor (suPAR) predict outcome after resection of cholangiocarcinoma (2019) (0)
From the Editor's Desk... (2023) (0)
Tim4high expression identifies a Kupffer cell subset with enhanced catching proficiency (2022) (0)
Preoperative Immunotherapy in Hepatocellular Carcinoma: Current State of the Art (2023) (0)
Evaluation of Fontan's Failure by Classifying the Severity of the Fontan-Associated Liver Disease—A Single-Centre Cross-Sectional Study (2021) (0)
From the Editor's Desk... (2022) (0)
410 Y-BOX PROTEIN-1/P18 FRAGMENT IDENTIFIES MALIGNANCIES IN PATIENTS WITH CHRONIC LIVER DISEASE (2008) (0)
Safety of add on Interferon-alpha-2a in hepatitis B patients receiving effective nucleos(t)de therapy: Interim results from the German multicenter PADD-ON trial (2014) (0)
Inhibition of LTβR signalling activates WNT-induced regeneration in lung (2020) (0)
Use of albumin infusion for cirrhosis-related complications: an international position statement (2023) (0)
Therapeutic modulation of the liver immune microenvironment. (2023) (0)
[Acute liver failure]. (2017) (0)
Synthetic integrin-binding immune stimulators target cancer cells and prevent tumor formation (2017) (0)
Effektive Glykolyse-Inhibierung im Citrat-gepufferten venösen Vollblut und Plasma/Effective inhibition of glycolysis in venous whole blood and plasma samples (2012) (0)
From the Editor's Desk…. (2020) (0)
Severe acute respiratory syndrome coronavirus 2 antibody prevalence in adult patients with short bowel syndrome—A German multicenter cross‐sectional study (2022) (0)
Associations between hepatitis B virus core gene mutations, immune escape and clinical presentation. (2012) (0)
Interventional gene targeting of the cell cycle regulator Cyclin E1 during hepatocarcinogenesis attenuates cancer progression with limited proliferation, stemness traits and micro-metastasis (2020) (0)
Contribution of E-type cyclins to hepatic fibrosis in human and mice (2010) (0)
Cyclin E1 is an essential pro-fibrotic factor in the liver (2010) (0)
From the Editor's Desk... (2021) (0)
590 MICRO-RNA PROFILING IN HUMAN SERUM REVEALS ETIOLOGY-INDEPENDENT, COMPARTMENT-SPECIFIC ROLES OF MIR-571 AND MIR-652 IN LIVER CIRRHOSIS (2012) (0)
Author Correction: Platelet GPIbα is a mediator and potential interventional target for NASH and subsequent liver cancer (2022) (0)
The authors reply. (2016) (0)
Evolution of naturally occurring Hepatitis B Virus Test and Immune Escape mutations facilitating persistence and symptomatic viral flare in an HIV-coinfected patient (2008) (0)
Soluble urokinase plasminogen activator receptor (suPAR) represents a novel serum biomarker for patients undergoing resection of colorectal liver metastases (2018) (0)
Hepatitis B virus (HBV) and delta virus (HDV) interactions : effects of HDV replication on drug resistance, immune escape and HBeAg-negative mutants of HBV (2016) (0)
Inflammatory Cytokines Associated with Diagnosis, Tumor Grade and Prognosis in Patients with Neuroendocrine Tumors (2022) (0)
From the Editor's Desk... (2020) (0)
Reprogramming necroptosis limits immune responses and prevents liver cancer development (2022) (0)
Global epidemiology of cirrhosis — aetiology, trends and predictions (2023) (0)
Cenicriviroc for the treatment of COVID-19: first interim results of a randomised, placebo-controlled, investigator-initiated, double-blind phase II trial (2022) (0)
CEA but not CA19-9 is an independent prognostic factor in patients undergoing resection of cholangiocarcinoma (2017) (0)
Contents (2020) (0)
MiR-122, the regulator of the immune privileged liver (2022) (0)
138 CROSSTALK BETWEEN c-myc OVEREXPRESSING HEPATOCYTES AND HEPATIC STELLATE CELLS FACILITATES THE ONSET OF LIVER FIBROSIS (2013) (0)
Validation of risk scores for allograft failure after liver transplantation in Germany: a retrospective cohort analysis (2023) (0)
An integrated view of anti-inflammatory and antifibrotic targets for the treatment of NASH. (2023) (0)
83 THE CHEMOKINE RECEPTOR CCR6 REDUCES LIVER INFLAMMATION AND FIBROSIS BY MEDIATING RECRUITMENT OF IL-17 PRODUCING GAMMA/DELTA T CELLS TO THE LIVER (2012) (0)
Post-treatment elevated gamma-glutamyl transferase is the best predictor for future outcomes in HCV patients achieving sustained virological response-data from the german hepatitis C-registry (DHC-R) (2022) (0)
From the Editor's Desk… (2020) (0)
126 The STAT signalling in hepatocytes is responsible for IL6/P130 dependent protection during concanavalin A-induced liver failure (2003) (0)
Homing in on the hepatic scar : recent advances in cell-specific targeting of liver fibrosis (2018) (0)
Novel drug discovery strategies for the treatment of decompensated cirrhosis (2021) (0)
Immune cell composition in cholangiopathies: Target and modulator of gut-to-liver signals in cholestatic liver injury (2022) (0)
A not so easy genotype—striking regional differences in SOF/RBV treatment responses in HCV GT2 (2017) (0)
FRI-208-Predictors of treatment response during addition of pegylated Interferon alfa-2a to an onging nucleos (t)id treatment in chronic hepatitis B: Results from the PADD-ON trial (2019) (0)
miR-193a-5 p regulates NUSAP1 expression to suppress hepatocarcinogenesis (2019) (0)
Cardiac Magnetic Resonance Reveals Incipient Cardiomyopathy Traits in Adult Patients With Phenylketonuria (2020) (0)
Comprehensive validation of different clinical prediction models on short- and long-term outcome following orthotopic liver transplantation (2018) (0)
From the Editor's Desk... (2023) (0)
Hepatic accumulation of IL-17 producing γδ T cells via chemokine receptor CCR6 restricts liver inflammation and fibrosis by inhibiting hepatic stellate cells (2013) (0)
The structure behind diversity: Covariance networks in hepatitis C virus sequences are associated with treatment response (2009) (0)
Leveraging weak complementary labels to improve semantic segmentation of hepatocellular carcinoma and cholangiocarcinoma in H&E-stained slides (2023) (0)
From the Editor’s Desk… (2022) (0)
The PDE-4 Inhibitor Roflumilast reduces weight gain, enhances insulin sensitivity and prevents hepatic steatosis in mice by increasing mitochondrogenesis (2014) (0)
The selective PDE-4 Inhibitor Roflumilast Reduces Body Weight, increased Insulin Sensitivity and reduces the non-alcoholic Fatty Liver Disease in Mice with elevated PKA-dependent activation of Mitochondria (2015) (0)
When malignancy hits twice – synchronous gastric carcinoma and non-Hodgkin-B-cell lymphoma in a patient with common variable immunodeficiency (2022) (0)
From the Editor’s Desk… (2001) (0)
Atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma: Results from a German real-world cohort. (2023) (0)
Acute Phase Proteins – Regulation and Functions of Acute Phase Proteins 212 2 . Obesity in critical disease (2012) (0)
Interventional targeting of Cyclin E1 during hepatocarcinogenesis limits stem cell traits and hepatic myeloid cell homing and attenuates cancer progression (2019) (0)
The Janus-like Face of IL-4Rα in Macrophages during Liver Fibrosis (2018) (0)
The chemokine receptor CXCR3 mediates NK cell recruitment and limits injury after toxic liver damage (2009) (0)
From the Editor's Desk... (2021) (0)
Exploring the potential of multiplex immunohistochemistry to unravel histological and immunological changes during non-alcoholic steatohepatitis and primary sclerosing cholangitis in human and mouse liver (2022) (0)
HMER_A_265473 125..138 (2020) (0)
Assessing the applicability of non-invasive diagnostic tests (NITs) in non-alcoholic fatty liver disease: an international qualitative study (2022) (0)
Combination therapy with a dual CCR2/CCR5 antagonist and a FGF21 analogue synergizes in ameliorating steatohepatitis and fibrosis (2020) (0)
Reply to 19-00977. (2019) (0)
BMP feed-forward loop promotes terminal differentiation in gastric glands and is interrupted by H. pylori-driven inflammation (2022) (0)
GLP-1 regulates the metabolic response during acute inflammation and predicts outcome in critically ill patients: central role of IL-6 (2014) (0)
Soluble urokinase plasminogen activator receptor (suPAR) predicts outcome after resection of biliary tract cancer (2020) (0)
A novel function of necroptosis in Non-Alcoholic Steatohepatitis (2015) (0)
Multiplex immunostaining and transcriptomic profiling identify novel immune cell markers for non-alcoholic steatohepatitis and primary sclerosing cholangitis (2022) (0)
The PDE-4 inhibitor roflumilast reduces body weight and improves glucose metabolism by increasing energy expenditure and mitochondrial respiration (2016) (0)
From the Editor's Desk... (2022) (0)
An Unexpected Line of Defense: Hepatoprotective Eosinophils in Ischemia‐Reperfusion Injury (2021) (0)
Polypharmacyand prevalence of multi drug-drug interactions in hepatitis C patients treated with pangenotypic direct acting antivirals: an analysis from three European countries (2023) (0)
Role of monocyte subsets in chronic liver injury and liver fibrosis (2009) (0)
Targeting liver fibrosis by siRNA-mediated inhibition of Cyclin E1 in mice (2015) (0)
Serum Interferon-gamma-inducible protein 10 (CXCL10) is a predictive marker of fibrosis progression after liver transplantation for hepatitis C infection (2011) (0)
P594 PROMOTION OF LIVER INJURY AND FIBROSIS BY THE LIVER-DERIVED PLASMA PROTEIN HISTIDINE-RICH GLYCOPROTEIN IS BASED ON POLARIZING HEPATIC MACROPHAGES TOWARDS THE INFLAMMATORY M1 PHENOTYPE (2014) (0)
From the Editor's Desk... (2021) (0)
Advances in the biology and therapy of Hepatitis B virus infection. (2006) (0)
miR-1224 is upregulated in hepatic ischemia-reperfusion injury and induces cell death via Sp1/Nfib inhibition (2015) (0)
From the Editor's Desk…. (2020) (0)
960 ENDOSCOPIC ULTRASOUND AS AN EARLY DIAGNOSTIC PROCEDURE FOR PRIMARY SCLEROSING CHOLANGITIS - A PROSPECTIVE PILOT STUDY (2012) (0)
Scheduled endoscopic program for patients with primary sclerosing cholangitis improves transplant-free survival and enables early risk stratification (2022) (0)
Subject Index Vol. 83, 2011 (2011) (0)
Western diet for 7 weeks in apolipoprotein-E-deficient mice induces non-alcoholic steatohepatitis with significant liver fibrosis and portal hypertension (2015) (0)
Targeting Liver Fibrosis by RNAi - Mediated Inhibition of Cyclin E1 (2016) (0)
Hepatic Fibrogenesis (2020) (0)
Antagonism of CCL5 chemokine receptors during regression of liver fibrosis is associated with an intrahepatic shift towards pro-inflammatory macrophages (2012) (0)
Contents (2020) (0)
Secreted Frizzled Related Protein 5 (SFRP5) Serum Levels Are Decreased in Critical Illness and Sepsis and Are Associated with Short-Term Mortality (2023) (0)
Evaluation of Inhibitory Antibodies against the Muscarinic Acetylcholine Receptor Type 3 in Patients with Primary Biliary Cholangitis and Primary Sclerosing Cholangitis (2022) (0)
Serum CXCL5 Detects Early Hepatocellular Carcinoma and Indicates Tumor Progression (2023) (0)
O025 : Role of CX3CL1-CX3CR1 axis for liver dendritic cell maturation in homeostasis and inflammation (2015) (0)
From the Editor's Desk... (2021) (0)
49 RECRUITMENT OF AN ANTI-INFLAMMATORY MONOCYTE SUBSET VIA CCR2/CCR6 AFTER ACUTE AND CHRONIC LIVER INJURY LIMITS LIVER FIBROSIS (2008) (0)
The authors reply. (2016) (0)
From the Editor's Desk... (2021) (0)
Non-Alcoholic Fatty Liver Disease in Patients with Polycystic Ovary Syndrome: A Systematic Review, Meta-Analysis, and Meta-Regression (2023) (0)
Effect of unsaturated fat and protein intake on liver fat in people at risk of unhealthy aging: 1-year results of a randomized controlled trial. (2023) (0)
Thrombopoietin serum levels are elevated in patients with chronic virus hepatitis and controlled on a post-transcriptional level (2002) (0)
[Use of Thrombopoetin-Receptor-Agonists (TPO-RA) in patients with liver cirrhosis before invasive procedures]. (2022) (0)
Visualization of remodeling of the extracellular matrix in the MCP-Knockout mouse in chronic myocardial infarction with an elastin-binding contrast agent (2013) (0)
OR4-3TARGETING LIVER INFLAMMATION USING MINCLE-TARGETED LIPOSOMES AS A NOVEL DRUG DELIVERY SYSTEM (2017) (0)
Molecular imaging of Cyclin E1 represents an indicator of acute and chronic liver disease (2015) (0)
Hepatitis D double reflex testing of all hepatitis B carriers in low HBV and high HBV/high HDV prevalence countries. (2023) (0)
From the Editor's Desk…. (2021) (0)
[Action algorithm: decompensated alcoholic liver cirrhosis in the emergency department]. (2022) (0)
[Management of acutely decompensated liver cirrhosis in emergency and critical care medicine]. (2021) (0)
Hospital mortality and current developments of liver transplantation in Germany: A systematic 10-year analysis (2021) (0)
From the Editor's Desk... (2022) (0)
960 Basal preS2/S-promoter activity and inducibility for hepatitis B virus surface antigen expression is controlled by CREB and PKA (2003) (0)
Anti-IL-10R treatment increases CD11b + Ly6C + monocytic cell percentages and serum CCL2 concentration during T. brucei infection. (2013) (0)
Circulating levels of soluble urokinase plasminogen activator receptor (suPAR) to predict outcome after resection of biliary tract cancer. (2020) (0)
Evidence for a heterodimeric structure of megalin in liver macrophages (2012) (0)
1105 PHARMACOLOGICAL INHIBITION OF CCL2 LIMITS ANGIOGENESIS ASSOCIATED WITH CHRONIC TOXIC LIVER INJURY IN VIVO BY RESTRAINING INFILTRATION OF PROANGIOGENIC INFLAMMATORY MONOCYTES (2013) (0)
Teduglutide treatment for chronic intestinal failure patients in germany – insights from a patient home care service program (2020) (0)
Review article: The need for more efficient and patient‐oriented drug development pathways in NASH—setting the scene for platform trials (2023) (0)
Hepatic accumulation and activation of CD8+ T cells aggravate acute liver injury (2017) (0)
1033 PHARMACOLOGICAL ANTAGONISM OF THE CHEMOKINE CCL2 (MCP-1) INHIBITS MACROPHAGE INFILTRATION INTO THE LIVER AND EXPERIMENTAL STEATOSIS IN VIVO (2011) (0)
Ghrelin is elevated in child C cirrhosis and clinical complications in patients with chronic liver diseases (2003) (0)
Hinzunahme von pegyliertem-Interferon-alpha zu einer bestehenden Nukleos(t)id-Analoga Therapie der HBeAg negativen Hepatitis B: Ergebnisse der prospektiven PADD-ON Studie (2018) (0)
Der lösliche Urokinase-Plasminogen-Aktivator Rezeptor (suPAR) als prognostischer Marker in Patienten mit resektablem cholangiozellulären Karzinom (2019) (0)
Die Bedeutung des endoskopischen Ultraschalls als diagnostisches Verfahren für die primär sklerosierende Cholangitis – eine prospektive Pilotstudie (2012) (0)
Retinol-Binding Protein 4 ist als Anti-Akutphaseprotein in kritisch kranken Patienten mit Insulinresistenz und Überleben auf Intensivstation assoziiert (2009) (0)
Bedeutung des Lymphknotenverteilungsmusters für die Prognose des Ileum-NET (2021) (0)
Bundesweite, multizentrische Studie zur Behandlung mit Teduglutid bei Kurzdarmpatienten in Deutschland - Erkenntnisse aus einem Patientenversorgungsprogramm (2020) (0)
Der Einsatz der immunonkologischen Therapie beim hepatozellulären Karzinom im Kontext der Lebertransplantation Eine interdisziplinäre Risiko-Nutzen-Abwägung (2021) (0)
Etablierung einer Methode zur Gewinnung von Komplement C3 (2014) (0)
Systematische Analyse zur Biodistribution von Nanopartikel-Klassen in der Leber, ein integrierter Ansatz zur Untersuchung der Gesamtorgan-Verteilung und der Rolle einzelner intrahepatischer Zelltypen (2016) (0)
Akute Darmblutung (2021) (0)
Die Kinase RIPK1 vermittelt eine neue molekulare Interaktion zwischen Entzündung und Zelltod in der Hepatokarzinogenese und Cholestase (2015) (0)
IL-6-abhängige GLP-1-Sekretion unter inflammatorischen Stimuli (2015) (0)
Nicht alkoholische Steatohepatitis (NASH) - Ursachen, Diagnostik und Therapie (2010) (0)
Transiente Leberelastografie ist ein valides Verfahren zur Erkennung von Leberfunktionsstörungen und hohem Sterblichkeitsrisiko bei kritisch kranken Patienten bei Aufnahme auf die Intensivstation (2011) (0)
Periphere und intrahepatische Monozyten-Subpopulationen sind mit Krankheitsaktivität und Leberfibrose in Patienten mit chronischen Lebererkrankungen assoziiert (2009) (0)
Resistin ist ein Prognosefaktor für das Überleben nicht-septischer Patienten in der Intensivmedizin (2009) (0)
CXCR3 -/- Muse zeigen eine verstrkte akute Leberschdigung nach CCl 4 Gabe (2008) (0)
Neuer Biomarker bei Sepsis-Patienten? (2014) (0)
Inflammatorische CD14+CD16+ Monozyten-Subpopulationen sind mit Krankheitsaktivität und Leberfibrose in Patienten mit chronischen Lebererkrankungen assoziiert (2009) (0)
Kompartimentelle Regulation von suPAR bei Patienten mit dekompensierter Leberzirrhose: Herkunft, Regulation und prognostische Relevanz (2013) (0)
Prognoseabschätzung der nichtalkoholischen Fettlebererkrankung (2010) (0)
Handlungsalgorithmus: dekompensierte äthyltoxische Leberzirrhose in der Notaufnahme (2022) (0)
Quantitative Analyse zur Differenzierung zwischen narbigen und entzündlichen Stenosen bei Patienten mit Morbus Crohn mithilfe der Kontrastmittelsonografie (Sonovue) (2009) (0)
Serumspiegel der Chemokin-Rezeptor CXCR3 Liganden sind in Patienten mit chronischen Lebererkrankungen erhöht und mit Krankheitsprogression, Leberfunktion und Komplikationen assoziiert (2011) (0)
Bioelektrische Impedanz Spektroskopie zur Überwachung und Verlaufskontrolle des Pleuraergusses (2017) (0)
Identifikation eines miRNA-133 basierten und sternzellspezifischen Regulationsmechanismus der Kollagensynthese in der Leberzirrhose (2012) (0)
Invasive Candida-Infektionen bei Leberzirrhose (2018) (0)
Sanierung von Nekrosen bei akuter Pankreatitis (2019) (0)
Diagnostische Algorithmen zum Staging hepatobiliärer Tumore (2021) (0)
Die RIP3-abhängige Nekroptose inhibiert die inflammatorische Hepatokarzinogenese durch eine Hemmung der Caspase-8- und JNK-abhängigen kompensatorischen Zellproliferation (2014) (0)
Identifikation eines organübergreifenden Netzwerkes TGF-beta abhängiger micro-RNAs in fibrotischen Erkrankungen (2015) (0)
CME Zertifizierte Fortbildung (2015) (0)
Intersektorales Management von Patienten mit unklarer Leberwerterhöhung und nichtalkoholischer Fettlebererkrankung (NAFLD) (2022) (0)
Identifikation einer Rolle der microRNA miR-29 in der Regulation in der Leberfibrose (2010) (0)
Darm-Leber-Achse – wie der Darm die Leber krank macht (2022) (0)
Leberfunktionsstörungen bei geriatrischen Patienten (2022) (0)
Diagnostik und stadienadaptierte Therapie der akuten Pankreatitis (2018) (0)
Ghrelin-Serumkonzentrationen sind bei kritisch kranken Patienten unabhängig von der zugrundeliegenden Ätiologie erhöht und sind Prädiktoren für eine günstige Prognose (2010) (0)
Differentieller Einfluss von HBeAg-negativen Stämmen auf die Replikationsfähigkeit von Entecavir-resistenten Hepatitis B Virus Mutationen (2009) (0)
Management der dekompensierten Leberzirrhose in der klinischen Akut‑, Notfall- und Intensivmedizin (2022) (0)
Der duale CCR2/CCR5 Antagonist Cenicriviroc reduziert die Infiltration pro-inflammatorischer CCR2+ Monozyten in Mausmodellen der akuten Leberschädigung (2015) (0)
Zwischenergebnisse der deutschlandweiten SARS-CoV-2 Antikörper Prävalenzstudie bei Patienten mit Kurzdarmsyndrom (CODAK Studie) (2021) (0)
Differentieller funktioneller Einfluss von HBeAg-negativen Precore- und Basal-Core-Promoter-Mutanten auf die Replikationseffizienz von Entecavir-resistenten Hepatitis B Virus Mutationen (2010) (0)
Differentieller funktioneller Einfluss der HBs-Immune-Escape Varianten G145R und P120T auf die Replikationseffizienz von Lamivudine-resistenten HBeAg-positiven und HBeAg-negativen Hepatitis B Virus Mutanten (2010) (0)
Niedrige SVR-Raten bei der Therapie der chronischen Hepatitis C-Virusinfektion vom Genotyp 2 mit Sofosbuvir und Ribavirin unter Real-World-Bedingungen: Deutsches Hepatitis C-Register (DHC-R) (2016) (0)
Prävalenz und Bedeutung inhibitorischer Auto-Antikörper gegen muskarinerge Acetylcholinrezeptoren vom Typ 3 bei Patienten mit primär biliärer Cholangitis – eine retrospektive Studie aus zwei universitären Zentren aus Berlin und Leipzig (2019) (0)
Der Fractalkine-Chemokinrezeptor CX3CR1 begrenzt Leberentzündung und Leberfibrose in vivo durch Kontrolle des Survivals intrahepatischer Makrophagen (2010) (0)
Zum Jahresschluss: Vielen Dank! (2020) (0)
DGVS Jahresrückblick 2021 (2021) (0)
Die Infiltration inflammatorischer Monozyten-Subpopulationen via CCR2 nach akuter und chronischer Leberschädigung ist wesentlich für die Leberfibrogenese (2008) (0)
Erratum: Die wichtigsten Neuerungen in der aktualisierten S2k-Leitlinie nicht-alkoholische Fettlebererkrankung der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) (2022) (0)
Stellenwert der endoskopischen Therapie von Komplikationen bariatrischer Chirurgie (2019) (0)
Systematische Gender-Diskriminierung durch die MELD-basierte Organvermittlung in der Lebertransplantation: Auswertungen der nationalen Registerdaten aus Deutschland und den USA (2021) (0)
Entwicklung eines neuen Assays zur Quantifizierung von Hepatitis B Virus-DNA sowie zur Unterscheidung zwischen HBV-Genotyp D und „non-D“ (2010) (0)
Multiple Primärtumoren bei einer intravenös strahlenexponierten Patientin (1999) (0)
Ursachen, patientenspezifische Risikofaktoren und Sterblichkeit bei Patienten mit gastrointestinalen Blutungen auf einer internistisch-gastroenterologischen Intensivstation im Zeitraum von 1999–2010 (2011) (0)
TAK1 kontrolliert einen NEMO-abhängigen, aber NF-kappaB-unabhängigen Signalweg in der Leberkrebsentstehung (2010) (0)
Der Chemokinrezeptor CXCR6 vermittelt die hepatische NKT-Zell-Akkumulation in chronischen Leberschädigungen und verstärkt die Entwicklung von Leberfibrose (2012) (0)
Drug-Drug-Interactions (DDIs) unter HCV-Therapie: Analgetika bei Suchtpatienten und Patienten mit Opioid-Substitutionstherapie (2020) (0)
Die CCAAT/enhancer binding protein beta (C/EBPb)–Isoformen LAP und LIP modulieren die Zellzyklusprogression nach partieller Hepatektomie (2004) (0)
Die atypische MAP Kinase NLK reguliert die Leberregeneration nach 2/3-Hepatektomie (2013) (0)
Der Fractalkine-Chemokinrezeptor CX3CR1 begrenzt Leberentzündung und Leberfibrose in vivo durch Regulation des Survivals intrahepatischer Monozyten und Makrophagen (2010) (0)
Aktuelle Therapieoptionen für die dekompensierte Leberzirrhose auf der Intensivstation (2014) (0)
Einfluss der Adhäsionsmoleküle MAdCAM-1 und ß7-Integrin auf die Pathogenese der ConA-induzierten Hepatitis (2016) (0)
Die pharmakologische Inhibition des Fettsäurerezeptors GPR84 reduziert Steatohepatitis und Fibrose durch eine verminderte Rekrutierung myeloider Zellen in Mausmodellen der chronischen Leberschädigung (2018) (0)
Die diagnostische Bedeutung des endoskopischen Ultraschalls bei Primär Sklerosierender Cholangitis: eine prospektive Pilotstudie (2012) (0)
Bewusstseinsstörungen aus toxikologischer Sicht (2016) (0)
Assoziation des rs4620530 Single Nucleotide Polymorphismus im muskarinergen Acetylcholinrezeptor Typ 3 Gen mit der primär biliären Cholangitis – eine retrospektive Analyse aus zwei universitären Zentren (2019) (0)
Pharmakologische Hemmung des Chemokins MCP-1 in der Regression der experimentellen Leberfibrose in Mausmodellen (2017) (0)
Erhöhte Manganwerte bei Patienten mit chronischem Darmversagen und parenteraler Ernährung - Ursache oder Folge der Hepatopathie? (2020) (0)
Identifikation eines miRNA-29 basierten Regulationsmechanismus in der Leberzirrhose (2011) (0)
Gastrointestinale Motilitätsstörungen bei Intensivpatienten (2022) (0)
Eine neue molekulare Interaktion zwischen IKKα/β und RIPK1 reguliert biliäre Homöostase und Hepatokarzinogenese (2016) (0)
Therapie des hepatozellulären Karzinoms – eine neue Dekade? (2021) (0)
Der lösliche Urokinase-Plasminogen-Aktivator Rezeptor (suPAR) als neuer diagnostischer und prognostischer Biomarker in der chronischen Lebererkrankung (2012) (0)
Prospektive diagnostische und prognostische Evaluation der transienten Leberelastographie bei kritisch kranken Patienten auf einer internistischen Intensivstation (2012) (0)
Der Chemokine Scavenger Rezeptor D6 führt zu einer verminderten Leberschädigung in einem akuten Schädigungsmodell durch die vermehrte Degradation inflammatorischer Chemokine (2009) (0)
Adaptive Immunität supprimiert Hepatokarzinogenese und Tumorwachstum im murinen DEN-Modell in vivo (2011) (0)
Leberfunktionsstörungen bei geriatrischen Patienten (2023) (0)
Ernährungstherapie des Intensivpatienten (2019) (0)
Aktuelle Entwicklungen in der Ernährungstherapie von Intensivpatienten (2018) (0)
Der duale CCR2/CCR5 Antagonist Cenicriviroc reduziert Steatohepatitis und Fibrose durch Inhibition infiltrierender pro-inflammatorischer CCR2+ Monozyten in Mausmodellen der chronischen Leberschädigung (2016) (0)
Interleukin-8 ist bei Patienten mit chronischen Lebererkrankungen aktiviert und mit der Akkumulation intrahepatischer Makrophagen in humaner Leberfibrose assoziiert (2011) (0)
Getriebeanordnung - insbesondere fuer vertikal-muehlen (1983) (0)
Der R-Spondin - Lgr4 Signalweg im Magen kontrolliert die Identität der Zellen in der Drüsenbasis und ermöglicht epitheliale Antworten auf eine H. pylori Infektion via Aktivierung von NF-κB (2021) (0)
Re-programmierung der Nekroptose limitiert Immunreaktionen und verhindert die Entstehung von Leberkrebs (2023) (0)
Die phänotypische Diversität von Monozyten und Makrophagen in der nicht-alkoholischen Fettlebererkrankung (2018) (0)
Vaskuläre Erkrankungen in Gastrointestinaltrakt und Leber (2021) (0)
Hepatische Dysfunktion bei Patienten mit kardiogenem Schock (2019) (0)
Diagnostik und Therapie der chronischen Hepatitis-B- und Hepatitis-D-Virus-Infektion (2013) (0)
Hohe Adiponectin-Serumspiegel sind ein negativer Prädiktor für das Überleben kritisch kranker Patienten (2010) (0)
Bedeutung von Hepatitis B Virus Core-Deletionen für die Virusreplikation und den klinischen Verlauf bei Patienten nach Nierentransplantation (2015) (0)
Einfluss von Tenofovir-Resistenz auf die Replikationsfähigkeit des Hepatitis B Virus bei HBeAg-positiven und HBeAg-negativen Stämmen (2008) (0)
Die TNF abhängige Minderexpression der miR-192 schützt vor dem Ischämie/Reperfusions-Schaden der Leber (2016) (0)
Einsatz von Thrombopoetin-Rezeptor-Agonisten (TPO-RA) vor invasiven Eingriffen bei Patienten mit Leberzirrhose (2022) (0)
Konzentrationszunahme von CML-modifizierten Serumproteinen bei chronischen Lebererkrankungen kann RAGE-Expression in HSC und MFB induzieren (2004) (0)
Die microRNA „miR-122“ ist bei der Aktivierung von hepatischen Sternzellen nicht reguliert (2016) (0)
Abstracts der 18. Jahrestagung (2009) (0)
Die rtA194T Polymerasemutation beeinflusst die Replikationsfähigkeit und Tenofovir-Empfindlichkeit des Hepatitis B Virus bei HBeAg-positiven und HBeAg-negativen Stämmen (2009) (0)
Die pharmakologische Hemmung infiltrierender CCR2+ Makrophagen reduziert Leberfibrose in Mausmodellen der nicht-alkoholischen Steatohepatitis (2017) (0)
Einsatz von Dexamethason-gekoppelten liposomalen Nanopartikeln in tierexperimentellen Modellen der akuten immunvermittelten Hepatitis (2014) (0)
Aktuelle Therapiekonzepte der chronischen Hepatitis-B-Infektion - Welche Patienten wann und wie behandeln? (2011) (0)
Neue Therapieoptionen für die Leberfibrose (2015) (0)
Die Repression von miR-192 schützt vor hepatischer Ischämie/Reperfusionsschädigung (2015) (0)
Infiltrierende inflammatorische Monozyten-Subpopulationen sind essentiell für die Progression der Leberfibrose (2009) (0)
miR-1224 ist hochreguliert im hepatischen Ischämie/Reperfusionsschaden und induziert Zelltod durch Inhibition von Sp1/Nfib (2016) (0)
Der Gastrointestinaltrakt in der Intensivmedizin – Übersicht 2020 (2020) (0)
Zum Jahresschluss: Vielen Dank! (2020) (0)
Die pharmakologische Inhibierung von MCP-1 (CCL2) verringert während chronischer Entzündung die Makrophagen-Infiltration in die Leber und die Steatohepatitis in vivo (2011) (0)
Erhöhte miR-122 Serumkonzentration stellen einen Biomarker für einen Leberschaden bei kritisch kranken Patienten dar (2014) (0)
Einsatz nicht-invasiver Leberfunktionstests bei Patienten mit chronischem Darmversagen und parenteraler Ernährung (2019) (0)
Die NF-kB abhängige Repression von miR-192 schützt in der hepatischen Ischämie/Reperfusionsschädigung (2015) (0)
Der Anfang vom Ende der Interferontherapie? – Neue interferonfreie Behandlungsoptionen für die Hepatitis C (2014) (0)
Hepatische Enzephalopathie und Sarkopenie: pathogenetische Bedeutung und therapeutische Implikationen von Ammoniak (2021) (0)
Entzündungsmechanismen im Rahmen der Progression der Fettleber als innovative molekulare Targets (2020) (0)
Ein zellspezifisches Netzwerk TGF-beta abhängiger micro-RNAs reguliert organübergreifende Prozesse in der Fibrogenese (2015) (0)
Autoren (2021) (0)
Mikrobiom & NASH – enge Komplizen in der Progression von Fettlebererkrankungen (2019) (0)
Ernährungstherapie des Intensivpatienten (2019) (0)
Das Histidin-reiche Glykoprotein führt über eine M1-Makrophagen-Polarisierung zu einer verstärkten chronischen Leberschädigung (2015) (0)
Management der dekompensierten Leberzirrhose in der klinischen Akut‑, Notfall- und Intensivmedizin (2021) (0)
Die microRNA „miR-122“ spielt keine Rolle bei der Aktivierung von hepatischen Sternzellen (2016) (0)
Interleukin-8 korreliert mit dem Schweregrad der Leberfibrose und –zirrhose und ist insbesondere assoziert mit cholestastischen Leberkrankungen (2011) (0)
Versorgung von Lebertransplantierten während der COVID-19-Pandemie (2023) (0)
Die Rolle von CCR2-exprimierenden, Ly6C-positiven Monozyten im Paracetamol-induzierten akuten Leberversagen und Effekte der pharmakologischen Blockade von CCR2 (2015) (0)
Ein Netzwerk TGF-beta-abhängiger miRNAs reguliert die sternzellspezifische Kollagenexpression in der Leberfibrose (2013) (0)
Reply (2019) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Frank Tacke?

Frank Tacke is affiliated with the following schools:

Humboldt University of Berlin
Icahn School of Medicine at Mount Sinai
RWTH Aachen University
Technical University of Munich
Leiden University

Frank Tacke's Academic­Influence.com Rankings

Why Is Frank Tacke Influential?

Frank Tacke's Published Works

Published Works

What Schools Are Affiliated With Frank Tacke?

Frank Tacke's AcademicInfluence.com Rankings